Array ( [0] => {{Short description|Lab technique in cellular biology}} [1] => {{cs1 config|name-list-style=vanc|display-authors=6}} [2] => {{Use dmy dates|date=October 2021}} [3] => [[File:Summary_of_RNA-Seq.svg|thumb|500x500px|''Summary of RNA-Seq.'' Within the organism, genes are transcribed and (in [4] => an [[eukaryote|eukaryotic organism]]) spliced to produce mature mRNA transcripts (red). The mRNA is extracted from the organism, fragmented and copied into stable ds-cDNA (blue). The ds-cDNA is sequenced using [[DNA sequencing#High-throughput methods|high-throughput]], short-read sequencing methods. These sequences can then be [[Sequence alignment|aligned]] to a reference genome sequence to reconstruct which genome regions were being transcribed. This data can be used to annotate where expressed genes are, their relative expression levels, and any alternative splice variants.{{cite journal | vauthors = Lowe R, Shirley N, Bleackley M, Dolan S, Shafee T | title = Transcriptomics technologies | journal = PLOS Computational Biology | volume = 13 | issue = 5 | pages = e1005457 | date = May 2017 | pmid = 28545146 | pmc = 5436640 | doi = 10.1371/journal.pcbi.1005457 | bibcode = 2017PLSCB..13E5457L | doi-access = free }}]] [5] => [6] => '''RNA-Seq''' (named as an abbreviation of '''RNA sequencing''') is a technique that uses [[next-generation sequencing]] to reveal the presence and quantity of [[RNA]] molecules in a biological sample, providing a snapshot of gene expression in the sample, also known as [[transcriptome]].{{cite journal | vauthors = Chu Y, Corey DR | title = RNA sequencing: platform selection, experimental design, and data interpretation | journal = Nucleic Acid Therapeutics | volume = 22 | issue = 4 | pages = 271–4 | date = August 2012 | pmid = 22830413 | pmc = 3426205 | doi = 10.1089/nat.2012.0367 }} [7] => [8] => Specifically, RNA-Seq facilitates the ability to look at [[Alternative splicing|alternative gene spliced transcripts]], [[post-transcriptional modification]]s, [[gene fusion]], mutations/[[single nucleotide polymorphism|SNPs]] and changes in [[gene expression]] over time, or differences in gene expression in different groups or treatments. In addition to mRNA transcripts, RNA-Seq can look at different populations of RNA to include total RNA, small RNA, such as [[miRNA]], [[tRNA]], and [[Ribosome profiling|ribosomal profiling]].{{cite journal | vauthors = Ingolia NT, Brar GA, Rouskin S, McGeachy AM, Weissman JS | title = The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments | journal = Nature Protocols | volume = 7 | issue = 8 | pages = 1534–50 | date = July 2012 | pmid = 22836135 | pmc = 3535016 | doi = 10.1038/nprot.2012.086 }} RNA-Seq can also be used to determine [[exon]]/[[intron]] boundaries and verify or amend previously [[Gene annotation|annotated]] [[Directionality (molecular biology)#5.E2.80.B2-end|5']] and [[Directionality (molecular biology)#3.E2.80.B2-end|3']] gene boundaries. Recent advances in RNA-Seq include [[Single-cell transcriptomics|single cell sequencing]], [[BRB-seq|bulk RNA sequencing]],{{cite journal | vauthors = Alpern D, Gardeux V, Russeil J, Mangeat B, Meireles-Filho AC, Breysse R, Hacker D, Deplancke B | title = BRB-seq: ultra-affordable high-throughput transcriptomics enabled by bulk RNA barcoding and sequencing | journal = Genome Biology | volume = 20 | issue = 1 | pages = 71 | date = April 2019 | pmid = 30999927 | pmc = 6474054 | doi = 10.1186/s13059-019-1671-x | doi-access = free }}, 3' mRNA-sequencing''',''' in situ sequencing of fixed tissue, and native RNA molecule sequencing with single-molecule real-time sequencing.{{cite journal | vauthors = Lee JH, Daugharthy ER, Scheiman J, Kalhor R, Yang JL, Ferrante TC, Terry R, Jeanty SS, Li C, Amamoto R, Peters DT, Turczyk BM, Marblestone AH, Inverso SA, Bernard A, Mali P, Rios X, Aach J, Church GM | title = Highly multiplexed subcellular RNA sequencing in situ | journal = Science | volume = 343 | issue = 6177 | pages = 1360–3 | date = March 2014 | pmid = 24578530 | pmc = 4140943 | doi = 10.1126/science.1250212 | bibcode = 2014Sci...343.1360L }} Other examples of emerging RNA-Seq applications due to the advancement of bioinformatics algorithms are copy number alteration, microbial contamination, transposable elements, cell type (deconvolution) and the presence of neoantigens.{{cite journal | vauthors = Thind AS, Monga I, Thakur PK, Kumari P, Dindhoria K, Krzak M, Ranson M, Ashford B | title = Demystifying emerging bulk RNA-Seq applications: the application and utility of bioinformatic methodology | journal = Briefings in Bioinformatics | volume = 22 | issue = 6 | date = November 2021 | pmid = 34329375 | doi = 10.1093/bib/bbab259 }} [9] => [10] => Prior to RNA-Seq, gene expression studies were done with hybridization-based [[DNA microarray|microarrays]]. Issues with microarrays include cross-hybridization artifacts, poor quantification of lowly and highly expressed genes, and needing to know the sequence [[A priori and a posteriori|''a priori'']].{{cite journal | vauthors = Kukurba KR, Montgomery SB | title = RNA Sequencing and Analysis | journal = Cold Spring Harbor Protocols | volume = 2015 | issue = 11 | pages = 951–69 | date = April 2015 | pmid = 25870306 | pmc = 4863231 | doi = 10.1101/pdb.top084970 }} Because of these technical issues, [[transcriptomics]] transitioned to sequencing-based methods. These progressed from [[Sanger sequencing]] of [[Expressed sequence tag]] libraries, to chemical tag-based methods (e.g., [[serial analysis of gene expression]]), and finally to the current technology, [[next-gen sequencing]] of [[complementary DNA]] (cDNA), notably RNA-Seq. [11] => [12] => [[File:RNA-seq.jpg|alt=First, cellular mRNA is extracted and fragmented into smaller mRNA sequences, which undergo reverse transcription. The resulting cDNAs are sequenced on a Next Generation Sequencing (NGS) platform. The results of such sequencing allow the generation of transcriptomic sequencing genomic maps.|thumb|Experimental transcriptome sequencing technique (RNA-seq).]] [13] => [14] => ==Methods== [15] => ===Library preparation=== [16] => {{See also|Library (biology)}} [17] => [[File:Journal.pcbi.1004393.g002.png|thumb|upright=1.75|Typical RNA-Seq experimental workflow. RNA are isolated from multiple samples, converted to cDNA libraries, sequenced into a computer-readable format, aligned to a reference, and quantified for downstream analyses such as differential expression and alternative splicing. Overview of a typical RNA-Seq experimental workflow.]] [18] => [19] => The general steps to prepare a [[complementary DNA]] (cDNA) library for sequencing are described below, but often vary between platforms.{{cite journal | vauthors = Griffith M, Walker JR, Spies NC, Ainscough BJ, Griffith OL | title = Informatics for RNA Sequencing: A Web Resource for Analysis on the Cloud | journal = PLOS Computational Biology | volume = 11 | issue = 8 | pages = e1004393 | date = August 2015 | pmid = 26248053 | pmc = 4527835 | doi = 10.1371/journal.pcbi.1004393 | bibcode = 2015PLSCB..11E4393G | doi-access = free }}{{cite journal | vauthors = Wang Z, Gerstein M, Snyder M | title = RNA-Seq: a revolutionary tool for transcriptomics | journal = Nature Reviews. Genetics | volume = 10 | issue = 1 | pages = 57–63 | date = January 2009 | pmid = 19015660 | pmc = 2949280 | doi = 10.1038/nrg2484 }}{{Cite web |url= http://rnaseq.uoregon.edu/ |title=RNA-seqlopedia |website=rnaseq.uoregon.edu |access-date=8 February 2017}} [20] => [21] => # ''RNA Isolation:'' [[RNA extraction|RNA is isolated]] from tissue and mixed with [[Deoxyribonuclease]] (DNase). DNase reduces the amount of genomic DNA. The amount of RNA degradation is checked with [[Gel electrophoresis|gel]] and [[capillary electrophoresis]] and is used to assign an [[RNA integrity number]] to the sample. This RNA quality and the total amount of starting RNA are taken into consideration during the subsequent library preparation, sequencing, and analysis steps. [22] => #''RNA selection/depletion:'' To analyze signals of interest, the isolated RNA can either be kept as is, enriched for RNA with [[w:Polyadenylation|3' polyadenylated (poly(A))]] tails to include only eukaryotic [[w:Messenger RNA|mRNA]], depleted of [[w:Ribosomal RNA|ribosomal RNA (rRNA)]], and/or filtered for RNA that binds specific sequences ('''RNA selection and depletion methods table''', below). RNA molecules having 3' poly(A) tails in eukaryotes are mainly composed of mature, processed, coding sequences. Poly(A) selection is performed by mixing RNA with {{not a typo|poly(T)}} oligomers covalently attached to a substrate, typically magnetic beads.{{cite journal | vauthors = Morin R, Bainbridge M, Fejes A, Hirst M, Krzywinski M, Pugh T, McDonald H, Varhol R, Jones S, Marra M | title = Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing | journal = BioTechniques | volume = 45 | issue = 1 | pages = 81–94 | date = July 2008 | pmid = 18611170 | doi = 10.2144/000112900 | doi-access = free }}{{cite journal | vauthors = Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B | title = Mapping and quantifying mammalian transcriptomes by RNA-Seq | journal = Nature Methods | volume = 5 | issue = 7 | pages = 621–8 | date = July 2008 | pmid = 18516045 | doi = 10.1038/nmeth.1226 | s2cid = 205418589 }} Poly(A) selection has important limitations in RNA biotype detection. Many RNA biotypes are not polyadenylated, including many noncoding RNA and histone-core protein transcripts, or are regulated via their poly(A) tail length (e.g., cytokines) and thus might not be detected after poly(A) selection.{{cite journal | vauthors = Sun Q, Hao Q, Prasanth KV | title = Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression | journal = Trends in Genetics | volume = 34 | issue = 2 | pages = 142–157 | date = February 2018 | pmid = 29249332 | pmc = 6002860 | doi = 10.1016/j.tig.2017.11.005 }} Furthermore, poly(A) selection may display increased 3' bias, especially with lower quality RNA.{{cite journal | vauthors = Sigurgeirsson B, Emanuelsson O, Lundeberg J | title = Sequencing degraded RNA addressed by 3' tag counting | journal = PLOS ONE | volume = 9 | issue = 3 | pages = e91851 | date = 2014 | pmid = 24632678 | pmc = 3954844 | doi = 10.1371/journal.pone.0091851 | bibcode = 2014PLoSO...991851S | doi-access = free }}{{cite journal | vauthors = Chen EA, Souaiaia T, Herstein JS, Evgrafov OV, Spitsyna VN, Rebolini DF, Knowles JA | title = Effect of RNA integrity on uniquely mapped reads in RNA-Seq | journal = BMC Research Notes | volume = 7 | pages = 753 | date = October 2014 | pmid = 25339126 | pmc = 4213542 | doi = 10.1186/1756-0500-7-753 | doi-access = free }} These limitations can be avoided with ribosomal depletion, removing rRNA that typically represents over 90% of the RNA in a cell. Both poly(A) enrichment and ribosomal depletion steps are labor intensive and could introduce biases, so more simple approaches have been developed to omit these steps.{{Cite journal| vauthors = Moll P, Ante M, Seitz A, Reda T |date=December 2014|title=QuantSeq 3′ mRNA sequencing for RNA quantification |journal=Nature Methods|language=en|volume=11|issue=12|pages=i–iii|doi=10.1038/nmeth.f.376|s2cid=83424788 |issn=1548-7105}} Small RNA targets, such as [[miRNA]], can be further isolated through size selection with exclusion gels, magnetic beads, or commercial kits. [23] => #''cDNA synthesis:'' RNA is [[Reverse transcriptase#Process of reverse transcription or retrotranscription|reverse transcribed]] to cDNA because DNA is more stable and to allow for amplification (which uses [[DNA polymerases]]) and leverage more mature DNA sequencing technology. Amplification subsequent to reverse transcription results in loss of [[Sense (molecular biology)|strandedness]], which can be avoided with chemical labeling or single molecule sequencing. Fragmentation and size selection are performed to purify sequences that are the appropriate length for the sequencing machine. The RNA, cDNA, or both are fragmented with enzymes, [[sonication]], or nebulizers. Fragmentation of the RNA reduces 5' bias of randomly primed-reverse transcription and the influence of [[Primer (molecular biology)|primer]] binding sites, with the downside that the 5' and 3' ends are converted to DNA less efficiently. Fragmentation is followed by size selection, where either small sequences are removed or a tight range of sequence lengths are selected. Because small RNAs like [[MicroRNA|miRNAs]] are lost, these are analyzed independently. The cDNA for each experiment can be indexed with a hexamer or octamer barcode, so that these experiments can be pooled into a single lane for multiplexed sequencing. [24] => {| class="wikitable" [25] => |+ style="text-align: left;" | RNA selection and depletion methods: [26] => |- [27] => ! Strategy !!Predominant type of RNA!! Ribosomal RNA content!!Unprocessed RNA content!!Isolation method [28] => |- [29] => | Total RNA ||All|| High || High || None [30] => |- [31] => | PolyA selection ||Coding|| Low || Low ||[[w:Nucleic acid hybridization|Hybridization]] with poly(dT) [[w:oligomer|oligomer]]s [32] => |- [33] => | rRNA depletion ||Coding, noncoding|| Low || High ||Removal of oligomers complementary to rRNA [34] => |- [35] => | RNA capture ||Targeted|| Low || Moderate ||Hybridization with probes complementary to desired transcripts [36] => |} [37] => [38] => === Complementary DNA sequencing (cDNA-Seq)=== [39] => {{See also|w:DNA sequencing}} [40] => [41] => The cDNA library derived from RNA biotypes is then sequenced into a computer-readable format. There are many high-throughput sequencing technologies for cDNA sequencing including platforms developed by [[w:Illumina, Inc.|Illumina]], [[w:Thermo Fisher Scientific|Thermo Fisher]], [[w:DNA nanoball sequencing|BGI/MGI]], [[w:Pacific Biosciences|PacBio]], and [[w:Oxford Nanopore Technologies|Oxford Nanopore Technologies]].{{cite journal | vauthors = Oikonomopoulos S, Bayega A, Fahiminiya S, Djambazian H, Berube P, Ragoussis J | title = Methodologies for Transcript Profiling Using Long-Read Technologies | language = English | journal = Frontiers in Genetics | volume = 11 | pages = 606 | date = 2020 | pmid = 32733532 | doi = 10.3389/fgene.2020.00606 | pmc = 7358353 | doi-access = free }} For Illumina short-read sequencing, a common technology for cDNA sequencing, adapters are ligated to the cDNA, DNA is attached to a flow cell, clusters are generated through cycles of bridge amplification and denaturing, and sequence-by-synthesis is performed in cycles of complementary strand synthesis and laser excitation of bases with reversible terminators. Sequencing platform choice and parameters are guided by experimental design and cost. Common experimental design considerations include deciding on the sequencing length, sequencing depth, use of single versus paired-end sequencing, number of replicates, multiplexing, randomization, and spike-ins.{{cite journal | vauthors = Conesa A, Madrigal P, Tarazona S, Gomez-Cabrero D, Cervera A, McPherson A, Szcześniak MW, Gaffney DJ, Elo LL, Zhang X, Mortazavi A | title = A survey of best practices for RNA-seq data analysis | journal = Genome Biology | volume = 17 | issue = 1 | pages = 13 | date = January 2016 | pmid = 26813401 | pmc = 4728800 | doi = 10.1186/s13059-016-0881-8 | doi-access = free }} [42] => [43] => ===Small RNA/non-coding RNA sequencing=== [44] => When sequencing RNA other than mRNA, the library preparation is modified. The cellular RNA is selected based on the desired size range. For small RNA targets, such as [[miRNA]], the RNA is isolated through size selection. This can be performed with a size exclusion gel, through size selection magnetic beads, or with a commercially developed kit. Once isolated, linkers are added to the 3' and 5' end then purified. The final step is [[Complementary DNA|cDNA]] generation through reverse transcription. [45] => [46] => ===Direct RNA sequencing=== [47] => [[File:RNASeqPics1.jpg|thumb]] [48] => Because converting RNA into [[Complementary DNA|cDNA]], ligation, amplification, and other sample manipulations have been shown to introduce biases and artifacts that may interfere with both the proper characterization and quantification of transcripts,{{cite journal | vauthors = Liu D, Graber JH | title = Quantitative comparison of EST libraries requires compensation for systematic biases in cDNA generation | journal = BMC Bioinformatics | volume = 7 | pages = 77 | date = February 2006 | pmid = 16503995 | pmc = 1431573 | doi = 10.1186/1471-2105-7-77 | doi-access = free }} single molecule direct RNA sequencing has been explored by companies including [[Helicos Biosciences|Helicos]] (bankrupt), [[Oxford Nanopore Technologies]],{{cite journal | vauthors = Garalde DR, Snell EA, Jachimowicz D, Sipos B, Lloyd JH, Bruce M, Pantic N, Admassu T, James P, Warland A, Jordan M, Ciccone J, Serra S, Keenan J, Martin S, McNeill L, Wallace EJ, Jayasinghe L, Wright C, Blasco J, Young S, Brocklebank D, Juul S, Clarke J, Heron AJ, Turner DJ | title = Highly parallel direct RNA sequencing on an array of nanopores | journal = Nature Methods | volume = 15 | issue = 3 | pages = 201–206 | date = March 2018 | pmid = 29334379 | doi = 10.1038/nmeth.4577 | s2cid = 3589823 }} and others. This technology sequences RNA molecules directly in a massively-parallel manner. [49] => [50] => ===Single-molecule real-time RNA sequencing=== [51] => {{See also|Single-molecule real-time sequencing}} [52] => Massively parallel single molecule direct RNA-Seq has been explored as an alternative to traditional RNA-Seq, in which RNA-to-[[w:Complementary DNA|cDNA]] conversion, ligation, amplification, and other sample manipulation steps may introduce biases and artifacts.{{cite journal | vauthors = Liu D, Graber JH | title = Quantitative comparison of EST libraries requires compensation for systematic biases in cDNA generation | journal = BMC Bioinformatics | volume = 7 | issue = | pages = 77 | date = February 2006 | pmid = 16503995 | pmc = 1431573 | doi = 10.1186/1471-2105-7-77 | doi-access = free }} Technology platforms that perform single-molecule real-time RNA-Seq include [[w:Oxford Nanopore Technologies|Oxford Nanopore Technologies (ONT)]] [[w:Nanopore sequencing|Nanopore sequencing]], [[w:Pacific Biosciences|PacBio]] IsoSeq, and [[w:Helicos Biosciences|Helicos]] (bankrupt). Sequencing RNA in its native form preserves modifications like methylation, allowing them to be investigated directly and simultaneously. Another benefit of single-molecule RNA-Seq is that transcripts can be covered in full length, allowing for higher confidence isoform detection and quantification compared to short-read sequencing. Traditionally, single-molecule RNA-Seq methods have higher error rates compared to short-read sequencing, but newer methods like ONT direct RNA-Seq limit errors by avoiding fragmentation and cDNA conversion. Recent uses of ONT direct RNA-Seq for differential expression in human cell populations have demonstrated that this technology can overcome many limitations of short and long cDNA sequencing.{{Cite journal| vauthors = Gleeson J, Lane TA, Harrison PJ, Haerty W, Clark MB |date=3 August 2020|title=Nanopore direct RNA sequencing detects differential expression between human cell populations |journal=bioRxiv|language=en|pages=2020.08.02.232785|doi=10.1101/2020.08.02.232785|s2cid=220975367|doi-access=free}} [53] => [54] => === Single-cell RNA sequencing (scRNA-Seq) === [55] => {{Main|Single-cell transcriptomics}} [56] => {{See also| Single cell sequencing}} [57] => Standard methods such as [[microarray]]s and standard bulk RNA-Seq analysis analyze the expression of RNAs from large populations of cells. In mixed cell populations, these measurements may obscure critical differences between individual cells within these populations."{{cite journal | vauthors = Shapiro E, Biezuner T, Linnarsson S | title = Single-cell sequencing-based technologies will revolutionize whole-organism science | journal = Nature Reviews. Genetics | volume = 14 | issue = 9 | pages = 618–30 | date = September 2013 | pmid = 23897237 | doi = 10.1038/nrg3542 | s2cid = 500845 }}"{{cite journal | vauthors = Kolodziejczyk AA, Kim JK, Svensson V, Marioni JC, Teichmann SA | title = The technology and biology of single-cell RNA sequencing | journal = Molecular Cell | volume = 58 | issue = 4 | pages = 610–20 | date = May 2015 | pmid = 26000846 | doi = 10.1016/j.molcel.2015.04.005 | doi-access = free }} [58] => [59] => Single-cell RNA sequencing (scRNA-Seq) provides the [[Gene expression profiling|expression profiles]] of individual cells. Although it is not possible to obtain complete information on every RNA expressed by each cell, due to the small amount of material available, patterns of gene expression can be identified through gene [[Cluster analysis|clustering analyses]]. This can uncover the existence of rare cell types within a cell population that may never have been seen before. For example, rare specialized cells in the lung called [[Lung#Protection|pulmonary ionocytes]] that express the [[Cystic fibrosis transmembrane conductance regulator]] were identified in 2018 by two groups performing scRNA-Seq on lung airway epithelia.{{cite journal | vauthors = Montoro DT, Haber AL, Biton M, Vinarsky V, Lin B, Birket SE, Yuan F, Chen S, Leung HM, Villoria J, Rogel N, Burgin G, Tsankov AM, Waghray A, Slyper M, Waldman J, Nguyen L, Dionne D, Rozenblatt-Rosen O, Tata PR, Mou H, Shivaraju M, Bihler H, Mense M, Tearney GJ, Rowe SM, Engelhardt JF, Regev A, Rajagopal J | title = A revised airway epithelial hierarchy includes CFTR-expressing ionocytes | journal = Nature | volume = 560 | issue = 7718 | pages = 319–324 | date = August 2018 | pmid = 30069044 | pmc = 6295155 | doi = 10.1038/s41586-018-0393-7 | bibcode = 2018Natur.560..319M }}{{cite journal | vauthors = Plasschaert LW, Žilionis R, Choo-Wing R, Savova V, Knehr J, Roma G, Klein AM, Jaffe AB | title = A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte | journal = Nature | volume = 560 | issue = 7718 | pages = 377–381 | date = August 2018 | pmid = 30069046 | pmc = 6108322 | doi = 10.1038/s41586-018-0394-6 | bibcode = 2018Natur.560..377P }} [60] => [61] => ==== Experimental procedures ==== [62] => [[File:RNA-Seq workflow-5.pdf|thumb|right|Typical single-cell RNA-Seq workflow. Single cells are isolated from a sample into either wells or droplets, cDNA libraries are generated and amplified, libraries are sequenced, and expression matrices are generated for downstream analyses like cell type identification.]] [63] => Current scRNA-Seq protocols involve the following steps: isolation of single cell and RNA, [[reverse transcription]] (RT), amplification, library generation and sequencing. Single cells are either mechanically separated into microwells (e.g., BD Rhapsody, Takara ICELL8, Vycap Puncher Platform, or CellMicrosystems CellRaft) or encapsulated in droplets (e.g., 10x Genomics Chromium, Illumina Bio-Rad ddSEQ, 1CellBio InDrop, Dolomite Bio Nadia).{{cite journal | vauthors = Valihrach L, Androvic P, Kubista M | title = Platforms for Single-Cell Collection and Analysis | journal = International Journal of Molecular Sciences | volume = 19 | issue = 3 | date = March 2018 | page = 807 | pmid = 29534489 | pmc = 5877668 | doi = 10.3390/ijms19030807 | doi-access = free }} Single cells are labeled by adding beads with barcoded oligonucleotides; both cells and beads are supplied in limited amounts such that co-occupancy with multiple cells and beads is a very rare event. Once reverse transcription is complete, the cDNAs from many cells can be mixed together for sequencing; transcripts from a particular cell are identified by each cell's unique barcode.{{cite journal | vauthors = Klein AM, Mazutis L, Akartuna I, Tallapragada N, Veres A, Li V, Peshkin L, Weitz DA, Kirschner MW | title = Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells | journal = Cell | volume = 161 | issue = 5 | pages = 1187–1201 | date = May 2015 | pmid = 26000487 | pmc = 4441768 | doi = 10.1016/j.cell.2015.04.044 }}{{cite journal | vauthors = Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, Tirosh I, Bialas AR, Kamitaki N, Martersteck EM, Trombetta JJ, Weitz DA, Sanes JR, Shalek AK, Regev A, McCarroll SA | title = Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets | journal = Cell | volume = 161 | issue = 5 | pages = 1202–1214 | date = May 2015 | pmid = 26000488 | pmc = 4481139 | doi = 10.1016/j.cell.2015.05.002 }} [[w:Unique molecular identifier|Unique molecular identifier (UMIs)]] can be attached to mRNA/cDNA target sequences to help identify artifacts during library preparation.{{cite journal | vauthors = Islam S, Zeisel A, Joost S, La Manno G, Zajac P, Kasper M, Lönnerberg P, Linnarsson S | title = Quantitative single-cell RNA-seq with unique molecular identifiers | journal = Nature Methods | volume = 11 | issue = 2 | pages = 163–6 | date = February 2014 | pmid = 24363023 | doi = 10.1038/nmeth.2772 | s2cid = 6765530 }} [64] => [65] => Challenges for scRNA-Seq include preserving the initial relative abundance of mRNA in a cell and identifying rare transcripts."{{cite journal | vauthors = Hebenstreit D | title = Methods, Challenges and Potentials of Single Cell RNA-seq | journal = Biology | volume = 1 | issue = 3 | pages = 658–67 | date = November 2012 | pmid = 24832513 | pmc = 4009822 | doi = 10.3390/biology1030658 | doi-access = free }}" The reverse transcription step is critical as the efficiency of the RT reaction determines how much of the cell's RNA population will be eventually analyzed by the sequencer. The processivity of reverse transcriptases and the priming strategies used may affect full-length cDNA production and the generation of libraries biased toward the 3’ or 5' end of genes. [66] => [67] => In the amplification step, either PCR or [[in vitro]] transcription (IVT) is currently used to amplify cDNA. One of the advantages of PCR-based methods is the ability to generate full-length cDNA. However, different PCR efficiency on particular sequences (for instance, GC content and snapback structure) may also be exponentially amplified, producing libraries with uneven coverage. On the other hand, while libraries generated by IVT can avoid PCR-induced sequence bias, specific sequences may be transcribed inefficiently, thus causing sequence drop-out or generating incomplete sequences.{{cite journal | vauthors = Eberwine J, Sul JY, Bartfai T, Kim J | title = The promise of single-cell sequencing | journal = Nature Methods | volume = 11 | issue = 1 | pages = 25–7 | date = January 2014 | pmid = 24524134 | doi = 10.1038/nmeth.2769 | s2cid = 11575439 }} [68] => Several scRNA-Seq protocols have been published: [69] => Tang et al.,{{cite journal | vauthors = Tang F, Barbacioru C, Wang Y, Nordman E, Lee C, Xu N, Wang X, Bodeau J, Tuch BB, Siddiqui A, Lao K, Surani MA | title = mRNA-Seq whole-transcriptome analysis of a single cell | journal = Nature Methods | volume = 6 | issue = 5 | pages = 377–82 | date = May 2009 | pmid = 19349980 | doi = 10.1038/NMETH.1315 | s2cid = 16570747 }} [70] => STRT,{{cite journal | vauthors = Islam S, Kjällquist U, Moliner A, Zajac P, Fan JB, Lönnerberg P, Linnarsson S | title = Characterization of the single-cell transcriptional landscape by highly multiplex RNA-seq | journal = Genome Research | volume = 21 | issue = 7 | pages = 1160–7 | date = July 2011 | pmid = 21543516 | pmc = 3129258 | doi = 10.1101/gr.110882.110 }} [71] => SMART-seq,{{cite journal | vauthors = Ramsköld D, Luo S, Wang YC, Li R, Deng Q, Faridani OR, Daniels GA, Khrebtukova I, Loring JF, Laurent LC, Schroth GP, Sandberg R | title = Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells | journal = Nature Biotechnology | volume = 30 | issue = 8 | pages = 777–82 | date = August 2012 | pmid = 22820318 | pmc = 3467340 | doi = 10.1038/nbt.2282 }} [72] => CEL-seq,{{cite journal | vauthors = Hashimshony T, Wagner F, Sher N, Yanai I | title = CEL-Seq: single-cell RNA-Seq by multiplexed linear amplification | journal = Cell Reports | volume = 2 | issue = 3 | pages = 666–73 | date = September 2012 | pmid = 22939981 | doi = 10.1016/j.celrep.2012.08.003 | doi-access = free }} [73] => RAGE-seq,{{cite journal| vauthors = Singh M, Al-Eryani G, Carswell S, Ferguson JM, Blackburn J, Barton K, Roden D, Luciani F, Phan T, Junankar S, Jackson K, Goodnow CC, Smith MA, Swarbrick A | title=High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytes |journal=bioRxiv|year=2018 | volume=10 | issue=1 | page=3120 |doi=10.1101/424945 | pmid=31311926 | pmc=6635368 |doi-access=free }} Quartz-seq{{cite journal | vauthors = Sasagawa Y, Nikaido I, Hayashi T, Danno H, Uno KD, Imai T, Ueda HR | title = Quartz-Seq: a highly reproducible and sensitive single-cell RNA sequencing method, reveals non-genetic gene-expression heterogeneity | journal = Genome Biology | volume = 14 | issue = 4 | pages = R31 | date = April 2013 | pmid = 23594475 | pmc = 4054835 | doi = 10.1186/gb-2013-14-4-r31 | doi-access = free }} and C1-CAGE.{{cite journal | vauthors = Kouno T, Moody J, Kwon AT, Shibayama Y, Kato S, Huang Y, Böttcher M, Motakis E, Mendez M, Severin J, Luginbühl J, Abugessaisa I, Hasegawa A, Takizawa S, Arakawa T, Furuno M, Ramalingam N, West J, Suzuki H, Kasukawa T, Lassmann T, Hon CC, Arner E, Carninci P, Plessy C, Shin JW | title = C1 CAGE detects transcription start sites and enhancer activity at single-cell resolution | journal = Nature Communications | volume = 10 | issue = 1 | pages = 360 | date = January 2019 | pmid = 30664627 | pmc = 6341120 | doi = 10.1038/s41467-018-08126-5 | bibcode = 2019NatCo..10..360K }} These protocols differ in terms of strategies for reverse transcription, cDNA synthesis and amplification, and the possibility to accommodate sequence-specific barcodes (i.e. [[Unique molecular identifier|UMIs]]) or the ability to process pooled samples.{{cite journal | vauthors = Dal Molin A, Di Camillo B | title = How to design a single-cell RNA-sequencing experiment: pitfalls, challenges and perspectives | journal = Briefings in Bioinformatics | volume = 20| issue = 4| pages = 1384–1394 | pmid = 29394315 | doi = 10.1093/bib/bby007 | year = 2019 }} [74] => [75] => In 2017, two approaches were introduced to simultaneously measure single-cell mRNA and protein expression through oligonucleotide-labeled antibodies known as REAP-seq,{{cite journal | vauthors = Peterson VM, Zhang KX, Kumar N, Wong J, Li L, Wilson DC, Moore R, McClanahan TK, Sadekova S, Klappenbach JA | title = Multiplexed quantification of proteins and transcripts in single cells | journal = Nature Biotechnology | volume = 35 | issue = 10 | pages = 936–939 | date = October 2017 | pmid = 28854175 | doi = 10.1038/nbt.3973 | first8 = Namit | first9 = Kelvin Xi | first6 = Lixia | first7 = Jerelyn | s2cid = 205285357 }} and CITE-seq.{{cite journal | vauthors = Stoeckius M, Hafemeister C, Stephenson W, Houck-Loomis B, Chattopadhyay PK, Swerdlow H, Satija R, Smibert P | title = Simultaneous epitope and transcriptome measurement in single cells | journal = Nature Methods | volume = 14 | issue = 9 | pages = 865–868 | date = September 2017 | pmid = 28759029 | pmc = 5669064 | doi = 10.1038/nmeth.4380 | first8 = Marlon | first5 = Brian | first6 = William | first7 = Christoph }} [76] => [77] => ==== Applications ==== [78] => scRNA-Seq is becoming widely used across biological disciplines including Development, [[Neurology]],{{cite journal | vauthors = Raj B, Wagner DE, McKenna A, Pandey S, Klein AM, Shendure J, Gagnon JA, Schier AF | title = Simultaneous single-cell profiling of lineages and cell types in the vertebrate brain | journal = Nature Biotechnology | volume = 36 | issue = 5 | pages = 442–450 | date = June 2018 | pmid = 29608178 | pmc = 5938111 | doi = 10.1038/nbt.4103 }} [[Oncology]],{{cite journal | vauthors = Olmos D, Arkenau HT, Ang JE, Ledaki I, Attard G, Carden CP, Reid AH, A'Hern R, Fong PC, Oomen NB, Molife R, Dearnaley D, Parker C, Terstappen LW, de Bono JS | title = Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience | journal = Annals of Oncology | volume = 20 | issue = 1 | pages = 27–33 | date = January 2009 | pmid = 18695026 | doi = 10.1093/annonc/mdn544 | doi-access = free }}{{cite journal | vauthors = Levitin HM, Yuan J, Sims PA | title = Single-Cell Transcriptomic Analysis of Tumor Heterogeneity | language = en | journal = Trends in Cancer | volume = 4 | issue = 4 | pages = 264–268 | date = April 2018 | pmid = 29606308 | pmc = 5993208 | doi = 10.1016/j.trecan.2018.02.003 | url = }}{{cite journal | vauthors = Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, Leeson R, Kanodia A, Mei S, Lin JR, Wang S, Rabasha B, Liu D, Zhang G, Margolais C, Ashenberg O, Ott PA, Buchbinder EI, Haq R, Hodi FS, Boland GM, Sullivan RJ, Frederick DT, Miao B, Moll T, Flaherty KT, Herlyn M, Jenkins RW, Thummalapalli R, Kowalczyk MS, Cañadas I, Schilling B, Cartwright AN, Luoma AM, Malu S, Hwu P, Bernatchez C, Forget MA, Barbie DA, Shalek AK, Tirosh I, Sorger PK, Wucherpfennig K, Van Allen EM, Schadendorf D, Johnson BE, Rotem A, Rozenblatt-Rosen O, Garraway LA, Yoon CH, Izar B, Regev A | title = A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade | language = en | journal = Cell | volume = 175 | issue = 4 | pages = 984–997.e24 | date = November 2018 | pmid = 30388455 | pmc = 6410377 | doi = 10.1016/j.cell.2018.09.006 | url = }} [[Autoimmune disease]],{{cite journal | vauthors = Stephenson W, Donlin LT, Butler A, Rozo C, Bracken B, Rashidfarrokhi A, Goodman SM, Ivashkiv LB, Bykerk VP, Orange DE, Darnell RB, Swerdlow HP, Satija R | title = Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation | journal = Nature Communications | volume = 9 | issue = 1 | pages = 791 | date = February 2018 | pmid = 29476078 | pmc = 5824814 | doi = 10.1038/s41467-017-02659-x | bibcode = 2018NatCo...9..791S }} and [[Infectious disease (medical specialty)|Infectious disease]].{{cite journal | vauthors = Avraham R, Haseley N, Brown D, Penaranda C, Jijon HB, Trombetta JJ, Satija R, Shalek AK, Xavier RJ, Regev A, Hung DT | title = Pathogen Cell-to-Cell Variability Drives Heterogeneity in Host Immune Responses | journal = Cell | volume = 162 | issue = 6 | pages = 1309–21 | date = September 2015 | pmid = 26343579 | pmc = 4578813 | doi = 10.1016/j.cell.2015.08.027 }} [79] => [80] => scRNA-Seq has provided considerable insight into the development of embryos and organisms, including the worm ''[[Caenorhabditis elegans]]'',{{cite journal | vauthors = Cao J, Packer JS, Ramani V, Cusanovich DA, Huynh C, Daza R, Qiu X, Lee C, Furlan SN, Steemers FJ, Adey A, Waterston RH, Trapnell C, Shendure J | title = Comprehensive single-cell transcriptional profiling of a multicellular organism | journal = Science | volume = 357 | issue = 6352 | pages = 661–667 | date = August 2017 | pmid = 28818938 | pmc = 5894354 | doi = 10.1126/science.aam8940 | bibcode = 2017Sci...357..661C }} and the regenerative planarian ''[[Schmidtea mediterranea]]''.{{cite journal | vauthors = Plass M, Solana J, Wolf FA, Ayoub S, Misios A, Glažar P, Obermayer B, Theis FJ, Kocks C, Rajewsky N | title = Cell type atlas and lineage tree of a whole complex animal by single-cell transcriptomics | journal = Science | volume = 360 | issue = 6391 | pages = eaaq1723 | date = May 2018 | pmid = 29674432 | doi = 10.1126/science.aaq1723 | doi-access = free }}{{cite journal | vauthors = Fincher CT, Wurtzel O, de Hoog T, Kravarik KM, Reddien PW | title = Schmidtea mediterranea | journal = Science | volume = 360 | issue = 6391 | pages = eaaq1736 | date = May 2018 | pmid = 29674431 | pmc = 6563842 | doi = 10.1126/science.aaq1736 }} The first vertebrate animals to be mapped in this way were [[Zebrafish]]{{cite journal | vauthors = Wagner DE, Weinreb C, Collins ZM, Briggs JA, Megason SG, Klein AM | title = Single-cell mapping of gene expression landscapes and lineage in the zebrafish embryo | journal = Science | volume = 360 | issue = 6392 | pages = 981–987 | date = June 2018 | pmid = 29700229 | pmc = 6083445 | doi = 10.1126/science.aar4362 | bibcode = 2018Sci...360..981W }}{{cite journal | vauthors = Farrell JA, Wang Y, Riesenfeld SJ, Shekhar K, Regev A, Schier AF | title = Single-cell reconstruction of developmental trajectories during zebrafish embryogenesis | journal = Science | volume = 360 | issue = 6392 | pages = eaar3131 | date = June 2018 | pmid = 29700225 | pmc = 6247916 | doi = 10.1126/science.aar3131 }} and ''[[Xenopus laevis]]''.{{cite journal | vauthors = Briggs JA, Weinreb C, Wagner DE, Megason S, Peshkin L, Kirschner MW, Klein AM | title = The dynamics of gene expression in vertebrate embryogenesis at single-cell resolution | journal = Science | volume = 360 | issue = 6392 | pages = eaar5780 | date = June 2018 | pmid = 29700227 | pmc = 6038144 | doi = 10.1126/science.aar5780 }} In each case multiple stages of the embryo were studied, allowing the entire process of development to be mapped on a cell-by-cell basis. [[Science Magazine|Science]] recognized these advances as the 2018 [[Breakthrough of the Year]].{{cite web |url= https://vis.sciencemag.org/breakthrough2018/finalists/ |title=Science's 2018 Breakthrough of the Year: tracking development cell by cell| vauthors = You J | work = Science Magazine | publisher = American Association for the Advancement of Science }} [81] => [82] => ===Experimental considerations=== [83] => [84] => A variety of [[parameters]] are considered when designing and conducting RNA-Seq experiments: [85] => [86] => * ''Tissue specificity:'' Gene expression varies within and between tissues, and RNA-Seq measures this mix of cell types. This may make it difficult to isolate the biological mechanism of interest. [[Single cell sequencing#Transcriptome sequencing (scRNA-seq)|Single cell sequencing]] can be used to study each cell individually, mitigating this issue. [87] => * ''Time dependence:'' Gene expression changes over time, and RNA-Seq only takes a snapshot. Time course experiments can be performed to observe changes in the transcriptome. [88] => * ''Coverage (also known as depth):'' RNA harbors the same mutations observed in DNA, and detection requires deeper coverage. With high enough coverage, RNA-Seq can be used to estimate the expression of each allele. This may provide insight into phenomena such as [[Genomic imprinting|imprinting]] or [[Cis-regulatory module|cis-regulatory effects]]. The depth of sequencing required for specific applications can be extrapolated from a pilot experiment. [89] => * ''Data generation artifacts (also known as technical variance):'' The reagents (e.g., library preparation kit), personnel involved, and type of sequencer (e.g., [[Illumina (company)|Illumina]], [[Pacific Biosciences]]) can result in technical artifacts that might be mis-interpreted as meaningful results. As with any scientific experiment, it is prudent to conduct RNA-Seq in a well controlled setting. If this is not possible or the study is a [[meta-analysis]], another solution is to detect technical artifacts by inferring [[latent variable]]s (typically [[principal component analysis]] or [[factor analysis]]) and subsequently correcting for these variables.{{cite journal | vauthors = Stegle O, Parts L, Piipari M, Winn J, Durbin R | title = Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses | journal = Nature Protocols | volume = 7 | issue = 3 | pages = 500–7 | date = February 2012 | pmid = 22343431 | pmc = 3398141 | doi = 10.1038/nprot.2011.457 }} [90] => * ''Data management:'' A single RNA-Seq experiment in humans is usually [[w:Gigabyte|1-5 Gb]] (compressed), or more when including intermediate files.{{cite journal | vauthors = Kingsford C, Patro R | title = Reference-based compression of short-read sequences using path encoding | journal = Bioinformatics | volume = 31 | issue = 12 | pages = 1920–8 | date = June 2015 | pmid = 25649622 | pmc = 4481695 | doi = 10.1093/bioinformatics/btv071 }} This large volume of data can pose storage issues. One solution is [[Data compression|compressing]] the data using multi-purpose computational schemas (e.g., [[gzip]]) or genomics-specific schemas. The latter can be based on reference sequences or de novo. Another solution is to perform microarray experiments, which may be sufficient for hypothesis-driven work or replication studies (as opposed to exploratory research). [91] => [92] => ==Analysis== [93] => {{See also|List of RNA-Seq bioinformatics tools}} [94] => [[file:RNASeqWorkflow2016.png|thumb|A standard RNA-Seq analysis workflow. Sequenced reads are aligned to a reference genome and/or transcriptome and subsequently processed for a variety of quality control, discovery, and hypothesis-driven analyses.]] [95] => [96] => ===Transcriptome assembly=== [97] => [98] => {{See also|Sequence alignment software#Short-Read Sequence Alignment}} [99] => [100] => Two methods are used to assign raw sequence reads to genomic features (i.e., assemble the transcriptome): [101] => [102] => * ''De novo:'' This approach does not require a [[w:reference genome|reference genome]] to reconstruct the transcriptome, and is typically used if the genome is unknown, incomplete, or substantially altered compared to the reference.{{cite journal | vauthors = Grabherr MG, Haas BJ, Yassour M, Levin JZ, Thompson DA, Amit I, Adiconis X, Fan L, Raychowdhury R, Zeng Q, Chen Z, Mauceli E, Hacohen N, Gnirke A, Rhind N, di Palma F, Birren BW, Nusbaum C, Lindblad-Toh K, Friedman N, Regev A | title = Full-length transcriptome assembly from RNA-Seq data without a reference genome | journal = Nature Biotechnology | volume = 29 | issue = 7 | pages = 644–52 | date = May 2011 | pmid = 21572440 | pmc = 3571712 | doi = 10.1038/nbt.1883 }} Challenges when using short reads for de novo assembly include 1) determining which reads should be joined together into contiguous sequences ([[w:contig|contig]]s), 2) robustness to sequencing errors and other artifacts, and 3) computational efficiency. The primary algorithm used for de novo assembly transitioned from overlap graphs, which identify all pair-wise overlaps between reads, to [[w:de Bruijn graph|de Bruijn graph]]s, which break reads into sequences of length k and collapse all k-mers into a hash table.{{cite web|title=De Novo Assembly Using Illumina Reads |url= http://www.illumina.com/Documents/products/technotes/technote_denovo_assembly_ecoli.pdf |access-date=22 October 2016 }} Overlap graphs were used with Sanger sequencing, but do not scale well to the millions of reads generated with RNA-Seq. Examples of assemblers that use de Bruijn graphs are Trinity, Oases[http://www.ebi.ac.uk/~zerbino/oases/ Oases: a transcriptome assembler for very short reads] (derived from the genome assembler [[w:Velvet (algorithm)|Velvet]]{{cite journal | vauthors = Zerbino DR, Birney E | title = Velvet: algorithms for de novo short read assembly using de Bruijn graphs | journal = Genome Research | volume = 18 | issue = 5 | pages = 821–9 | date = May 2008 | pmid = 18349386 | pmc = 2336801 | doi = 10.1101/gr.074492.107 }}), Bridger,{{cite journal | vauthors = Chang Z, Li G, Liu J, Zhang Y, Ashby C, Liu D, Cramer CL, Huang X | title = Bridger: a new framework for de novo transcriptome assembly using RNA-seq data | journal = Genome Biology | volume = 16 | issue = 1 | pages = 30 | date = February 2015 | pmid = 25723335 | pmc = 4342890 | doi = 10.1186/s13059-015-0596-2 | doi-access = free }} and rnaSPAdes.{{cite journal | vauthors = Bushmanova E, Antipov D, Lapidus A, Prjibelski AD | title = rnaSPAdes: a de novo transcriptome assembler and its application to RNA-Seq data | journal = GigaScience | volume = 8 | issue = 9 | date = September 2019 | pmid = 31494669 | pmc = 6736328 | doi = 10.1093/gigascience/giz100 }} Paired-end and long-read sequencing of the same sample can mitigate the deficits in short read sequencing by serving as a template or skeleton. Metrics to assess the quality of a de novo assembly include median contig length, number of contigs and [[w:N50, L50, and related statistics|N50]].{{cite journal | vauthors = Li B, Fillmore N, Bai Y, Collins M, Thomson JA, Stewart R, Dewey CN | title = Evaluation of de novo transcriptome assemblies from RNA-Seq data | journal = Genome Biology | volume = 15 | issue = 12 | pages = 553 | date = December 2014 | pmid = 25608678 | pmc = 4298084 | doi = 10.1186/s13059-014-0553-5 | doi-access = free }} [103] => [104] => [[file:RNA-Seq-alignment.png|thumb|RNA-Seq alignment with intron-split short reads. Alignment of short reads to an mRNA sequence and the reference genome. Alignment software has to account for short reads that overlap exon-exon junctions (in red) and thereby skip intronic sections of the pre-mRNA and reference genome.]] [105] => [106] => * ''Genome guided:'' This approach relies on the same methods used for DNA alignment, with the additional complexity of aligning reads that cover non-continuous portions of the reference genome.{{cite journal | vauthors = Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR | title = STAR: ultrafast universal RNA-seq aligner | journal = Bioinformatics | volume = 29 | issue = 1 | pages = 15–21 | date = January 2013 | pmid = 23104886 | pmc = 3530905 | doi = 10.1093/bioinformatics/bts635 }} These non-continuous reads are the result of sequencing spliced transcripts (see figure). Typically, alignment algorithms have two steps: 1) align short portions of the read (i.e., seed the genome), and 2) use [[dynamic programming]] to find an optimal alignment, sometimes in combination with known annotations. Software tools that use genome-guided alignment include [[Bowtie (sequence analysis)|Bowtie]],{{cite journal | vauthors = [[Ben Langmead|Langmead B]], Trapnell C, Pop M, Salzberg SL | title = Ultrafast and memory-efficient alignment of short DNA sequences to the human genome | journal = Genome Biology | volume = 10 | issue = 3 | pages = R25 | date = 2009 | pmid = 19261174 | pmc = 2690996 | doi = 10.1186/gb-2009-10-3-r25 | doi-access = free }} [[TopHat (bioinformatics)|TopHat]] (which builds on BowTie results to align splice junctions),{{cite journal | vauthors = Trapnell C, [[Lior Pachter|Pachter L]], [[Steven Salzberg|Salzberg SL]] | title = TopHat: discovering splice junctions with RNA-Seq | journal = Bioinformatics | volume = 25 | issue = 9 | pages = 1105–11 | date = May 2009 | pmid = 19289445 | pmc = 2672628 | doi = 10.1093/bioinformatics/btp120 }}{{cite journal | vauthors = Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L | title = Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks | journal = Nature Protocols | volume = 7 | issue = 3 | pages = 562–78 | date = March 2012 | pmid = 22383036 | pmc = 3334321 | doi = 10.1038/nprot.2012.016 }} Subread,{{cite journal | vauthors = Liao Y, Smyth GK, Shi W | title = The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote | journal = Nucleic Acids Research | volume = 41 | issue = 10 | pages = e108 | date = May 2013 | pmid = 23558742 | pmc = 3664803 | doi = 10.1093/nar/gkt214 }} STAR, HISAT2,{{cite journal | vauthors = Kim D, Langmead B, Salzberg SL | title = HISAT: a fast spliced aligner with low memory requirements | journal = Nature Methods | volume = 12 | issue = 4 | pages = 357–60 | date = April 2015 | pmid = 25751142 | pmc = 4655817 | doi = 10.1038/nmeth.3317 }} and GMAP.{{cite journal | vauthors = Wu TD, Watanabe CK | title = GMAP: a genomic mapping and alignment program for mRNA and EST sequences | journal = Bioinformatics | volume = 21 | issue = 9 | pages = 1859–75 | date = May 2005 | pmid = 15728110 | doi = 10.1093/bioinformatics/bti310 | doi-access = free }} The output of genome guided alignment (mapping) tools can be further used by tools such as Cufflinks or StringTie{{cite journal | vauthors = Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL | title = StringTie enables improved reconstruction of a transcriptome from RNA-seq reads | journal = Nature Biotechnology | volume = 33 | issue = 3 | pages = 290–5 | date = March 2015 | pmid = 25690850 | pmc = 4643835 | doi = 10.1038/nbt.3122 }} to reconstruct contiguous transcript sequences (''i.e.'', a FASTA file). The quality of a genome guided assembly can be measured with both 1) de novo assembly metrics (e.g., N50) and 2) comparisons to known transcript, splice junction, genome, and protein sequences using [[w:Precision and recall|precision, recall]], or their combination (e.g., F1 score). In addition, ''in silico'' assessment could be performed using simulated reads.{{cite journal | vauthors = Baruzzo G, Hayer KE, Kim EJ, Di Camillo B, FitzGerald GA, Grant GR | title = Simulation-based comprehensive benchmarking of RNA-seq aligners | language = En | journal = Nature Methods | volume = 14 | issue = 2 | pages = 135–139 | date = February 2017 | pmid = 27941783 | pmc = 5792058 | doi = 10.1038/nmeth.4106 }}{{cite journal | vauthors = Engström PG, Steijger T, Sipos B, Grant GR, Kahles A, Rätsch G, Goldman N, Hubbard TJ, Harrow J, Guigó R, Bertone P | title = Systematic evaluation of spliced alignment programs for RNA-seq data | language = En | journal = Nature Methods | volume = 10 | issue = 12 | pages = 1185–91 | date = December 2013 | pmid = 24185836 | pmc = 4018468 | doi = 10.1038/nmeth.2722 }} [107] => [108] => ''A note on assembly quality:'' The current consensus is that 1) assembly quality can vary depending on which metric is used, 2) assembly tools that scored well in one species do not necessarily perform well in the other species, and 3) combining different approaches might be the most reliable.{{cite journal | vauthors = Lu B, Zeng Z, Shi T | title = Comparative study of de novo assembly and genome-guided assembly strategies for transcriptome reconstruction based on RNA-Seq | journal = Science China Life Sciences | volume = 56 | issue = 2 | pages = 143–55 | date = February 2013 | pmid = 23393030 | doi = 10.1007/s11427-013-4442-z | doi-access = free }}{{cite journal | vauthors = Bradnam KR, Fass JN, Alexandrov A, Baranay P, Bechner M, Birol I, Boisvert S, Chapman JA, Chapuis G, Chikhi R, Chitsaz H, Chou WC, Corbeil J, Del Fabbro C, Docking TR, Durbin R, Earl D, Emrich S, Fedotov P, Fonseca NA, Ganapathy G, Gibbs RA, Gnerre S, Godzaridis E, Goldstein S, Haimel M, Hall G, Haussler D, Hiatt JB, Ho IY, Howard J, Hunt M, Jackman SD, Jaffe DB, Jarvis ED, Jiang H, Kazakov S, Kersey PJ, Kitzman JO, Knight JR, Koren S, Lam TW, Lavenier D, Laviolette F, Li Y, Li Z, Liu B, Liu Y, Luo R, Maccallum I, Macmanes MD, Maillet N, Melnikov S, Naquin D, Ning Z, Otto TD, Paten B, Paulo OS, Phillippy AM, Pina-Martins F, Place M, Przybylski D, Qin X, Qu C, Ribeiro FJ, Richards S, Rokhsar DS, Ruby JG, Scalabrin S, Schatz MC, Schwartz DC, Sergushichev A, Sharpe T, Shaw TI, Shendure J, Shi Y, Simpson JT, Song H, Tsarev F, Vezzi F, Vicedomini R, Vieira BM, Wang J, Worley KC, Yin S, Yiu SM, Yuan J, Zhang G, Zhang H, Zhou S, Korf IF | title = Assemblathon 2: evaluating de novo methods of genome assembly in three vertebrate species | journal = GigaScience | volume = 2 | issue = 1 | pages = 10 | date = July 2013 | pmid = 23870653 | pmc = 3844414 | doi = 10.1186/2047-217X-2-10 | bibcode = 2013arXiv1301.5406B | arxiv = 1301.5406 | doi-access = free }}{{cite journal | vauthors = Hölzer M, Marz M | title = De novo transcriptome assembly: A comprehensive cross-species comparison of short-read RNA-Seq assemblers | journal = GigaScience | volume = 8 | issue = 5 | date = May 2019 | pmid = 31077315 | pmc = 6511074 | doi = 10.1093/gigascience/giz039 }} [109] => [110] => ===Gene expression quantification=== [111] => [112] => Expression is quantified to study cellular changes in response to external stimuli, differences between healthy and [[w:diseased|diseased]] states, and other research questions. Transcript levels are often used as a proxy for protein abundance, but these are often not equivalent due to post transcriptional events such as [[w:RNA interference|RNA interference]] and [[w:nonsense-mediated decay|nonsense-mediated decay]].{{cite journal | vauthors = Greenbaum D, Colangelo C, Williams K, Gerstein M | title = Comparing protein abundance and mRNA expression levels on a genomic scale | journal = Genome Biology | volume = 4 | issue = 9 | pages = 117 | year = 2003 | pmid = 12952525 | pmc = 193646 | doi = 10.1186/gb-2003-4-9-117 | doi-access = free }} [113] => [114] => Expression is quantified by counting the number of reads that mapped to each locus in the [[w:RNA-Seq#Transcriptome assembly|transcriptome assembly]] step. Expression can be quantified for exons or genes using contigs or reference transcript annotations. These observed RNA-Seq read counts have been robustly validated against older technologies, including expression microarrays and [[w:Real-time polymerase chain reaction|qPCR]].{{cite journal | vauthors = Li H, Lovci MT, Kwon YS, Rosenfeld MG, Fu XD, Yeo GW | title = Determination of tag density required for digital transcriptome analysis: application to an androgen-sensitive prostate cancer model | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 105 | issue = 51 | pages = 20179–84 | date = December 2008 | pmid = 19088194 | pmc = 2603435 | doi = 10.1073/pnas.0807121105 | bibcode = 2008PNAS..10520179L | doi-access = free }}{{cite journal | vauthors = Zhang ZH, Jhaveri DJ, Marshall VM, Bauer DC, Edson J, Narayanan RK, Robinson GJ, Lundberg AE, Bartlett PF, Wray NR, Zhao QY | title = A comparative study of techniques for differential expression analysis on RNA-Seq data | journal = PLOS ONE | volume = 9 | issue = 8 | pages = e103207 | date = August 2014 | pmid = 25119138 | doi = 10.1371/journal.pone.0103207 | pmc=4132098| bibcode = 2014PLoSO...9j3207Z | doi-access = free }} Tools that quantify counts are HTSeq,{{cite journal | vauthors = Anders S, Pyl PT, Huber W | title = HTSeq--a Python framework to work with high-throughput sequencing data | journal = Bioinformatics | volume = 31 | issue = 2 | pages = 166–9 | date = January 2015 | pmid = 25260700 | pmc = 4287950 | doi = 10.1093/bioinformatics/btu638 }} FeatureCounts,{{cite journal | vauthors = Liao Y, Smyth GK, Shi W | title = featureCounts: an efficient general purpose program for assigning sequence reads to genomic features | journal = Bioinformatics | volume = 30 | issue = 7 | pages = 923–30 | date = April 2014 | pmid = 24227677 | doi = 10.1093/bioinformatics/btt656 | arxiv = 1305.3347 }} Rcount,{{cite journal | vauthors = Schmid MW, Grossniklaus U | title = Rcount: simple and flexible RNA-Seq read counting | journal = Bioinformatics | volume = 31 | issue = 3 | pages = 436–7 | date = February 2015 | pmid = 25322836 | doi = 10.1093/bioinformatics/btu680 | doi-access = free }} maxcounts,{{cite journal | vauthors = Finotello F, Lavezzo E, Bianco L, Barzon L, Mazzon P, Fontana P, Toppo S, Di Camillo B | title = Reducing bias in RNA sequencing data: a novel approach to compute counts | journal = BMC Bioinformatics | volume = 15 | issue = Suppl 1 | pages = S7 | date = 2014 | pmid = 24564404 | pmc = 4016203 | doi = 10.1186/1471-2105-15-s1-s7 | doi-access = free }} FIXSEQ,{{cite journal | vauthors = Hashimoto TB, Edwards MD, Gifford DK | title = Universal count correction for high-throughput sequencing | journal = PLOS Computational Biology | volume = 10 | issue = 3 | pages = e1003494 | date = March 2014 | pmid = 24603409 | pmc = 3945112 | doi = 10.1371/journal.pcbi.1003494 | bibcode = 2014PLSCB..10E3494H | doi-access = free }} and Cuffquant. These tools determine read counts from aligned RNA-Seq data, but alignment-free counts can also be obtained with Sailfish{{cite journal|date=May 2014|title=Sailfish enables alignment-free isoform quantification from RNA-seq reads using lightweight algorithms|journal=Nature Biotechnology|volume=32|issue=5|pages=462–4|arxiv=1308.3700|doi=10.1038/nbt.2862|pmc=4077321|pmid=24752080|vauthors=Patro R, Mount SM, Kingsford C}} and Kallisto.{{cite journal|date=May 2016|title=Near-optimal probabilistic RNA-seq quantification|journal=Nature Biotechnology|volume=34|issue=5|pages=525–7|doi=10.1038/nbt.3519|pmid=27043002|vauthors=Bray NL, Pimentel H, Melsted P, Pachter L|s2cid=205282743|url=https://resolver.caltech.edu/CaltechAUTHORS:20190506-110012992 }} The read counts are then converted into appropriate metrics for hypothesis testing, regressions, and other analyses. Parameters for this conversion are: [115] => [116] => * ''[[w:Coverage (genetics)|Sequencing depth/coverage]]:'' Although depth is pre-specified when conducting multiple RNA-Seq experiments, it will still vary widely between experiments.{{cite journal | author1 = Robinson MD| author2 = Oshlack A | author-link2 = Alicia Oshlack | title = A scaling normalization method for differential expression analysis of RNA-seq data | journal = Genome Biology | volume = 11 | issue = 3 | pages = R25 | date = 2010 | pmid = 20196867 | pmc = 2864565 | doi = 10.1186/gb-2010-11-3-r25 | doi-access = free }} Therefore, the total number of reads generated in a single experiment is typically normalized by converting counts to fragments, reads, or counts per million mapped reads (FPM, RPM, or CPM). The difference between RPM and FPM was historically derived during the evolution from single-end sequencing of fragments to paired-end sequencing. In single-end sequencing, there is only one read per fragment (''i.e.'', RPM = FPM). In paired-end sequencing, there are two reads per fragment (''i.e.'', RPM = 2 x FPM). Sequencing depth is sometimes referred to as [[w:Library (biology)|library size]], the number of intermediary cDNA molecules in the experiment. [117] => * ''Gene length:'' Longer genes will have more fragments/reads/counts than shorter genes if transcript expression is the same. This is adjusted by dividing the FPM by the length of a feature (which can be a gene, transcript, or exon), resulting in the metric fragments per kilobase of feature per million mapped reads (FPKM).{{cite journal | vauthors = Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L | title = Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation | journal = Nature Biotechnology | volume = 28 | issue = 5 | pages = 511–5 | date = May 2010 | pmid = 20436464 | pmc = 3146043 | doi = 10.1038/nbt.1621 | author9-link = Lior Pachter }} When looking at groups of features across samples, FPKM is converted to transcripts per million (TPM) by dividing each FPKM by the sum of FPKMs within a sample.{{cite arXiv| vauthors = Pachter L |title=Models for transcript quantification from RNA-Seq|eprint=1104.3889|date=19 April 2011|class=q-bio.GN}}{{cite web|title=What the FPKM? A review of RNA-Seq expression units|url=https://haroldpimentel.wordpress.com/2014/05/08/what-the-fpkm-a-review-rna-seq-expression-units/|website=The farrago|access-date=28 March 2018|date=8 May 2014}}{{cite journal | vauthors = Wagner GP, Kin K, Lynch VJ | title = Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples | journal = Theory in Biosciences | volume = 131 | issue = 4 | pages = 281–5 | date = December 2012 | pmid = 22872506 | doi = 10.1007/s12064-012-0162-3 | s2cid = 16752581 }} [118] => * ''Total sample RNA output:'' Because the same amount of RNA is extracted from each sample, samples with more total RNA will have less RNA per gene. These genes appear to have decreased expression, resulting in false positives in downstream analyses. Normalization strategies including quantile, DESeq2, TMM and Median Ratio attempt to account for this difference by comparing a set of non-differentially expressed genes between samples and scaling accordingly.{{cite journal | vauthors = Evans C, Hardin J, Stoebel DM | title = Selecting between-sample RNA-Seq normalization methods from the perspective of their assumptions | journal = Briefings in Bioinformatics | volume = 19 | issue = 5 | pages = 776–792 | date = September 2018 | pmid = 28334202 | pmc = 6171491 | doi = 10.1093/bib/bbx008 }} [119] => * ''[[Variance]] for each gene's expression:'' is modeled to account for [[sampling error]] (important for genes with low read counts), increase power, and decrease false positives. Variance can be estimated as a [[Normal distribution|normal]], [[Poisson distribution|Poisson]], or [[Negative binomial distribution|negative binomial]] distribution{{cite journal | vauthors = Law CW, Chen Y, Shi W, Smyth GK | title = voom: Precision weights unlock linear model analysis tools for RNA-seq read counts | journal = Genome Biology | volume = 15 | issue = 2 | pages = R29 | date = February 2014 | pmid = 24485249 | pmc = 4053721 | doi = 10.1186/gb-2014-15-2-r29 | doi-access = free }}{{cite journal | vauthors = Anders S, Huber W | title = Differential expression analysis for sequence count data | journal = Genome Biology | volume = 11 | issue = 10 | pages = R106 | date = 2010 | pmid = 20979621 | pmc = 3218662 | doi = 10.1186/gb-2010-11-10-r106 | doi-access = free }}{{cite journal | vauthors = Robinson MD, McCarthy DJ, Smyth GK | title = edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | journal = Bioinformatics | volume = 26 | issue = 1 | pages = 139–40 | date = January 2010 | pmid = 19910308 | pmc = 2796818 | doi = 10.1093/bioinformatics/btp616 }} and is frequently decomposed into technical and biological variance. [120] => [121] => ==== Spike-ins for absolute quantification and detection of genome-wide effects ==== [122] => [[w:RNA spike-in|RNA spike-ins]] are samples of RNA at known concentrations that can be used as gold standards in experimental design and during downstream analyses for absolute quantification and detection of genome-wide effects. [123] => [124] => * ''Absolute quantification:'' Absolute quantification of gene expression is not possible with most RNA-Seq experiments, which quantify expression relative to all transcripts. It is possible by performing RNA-Seq with spike-ins, samples of RNA at known concentrations. After sequencing, read counts of spike-in sequences are used to determine the relationship between each gene's read counts and absolute quantities of biological fragments.{{cite journal | vauthors = Marguerat S, Schmidt A, Codlin S, Chen W, Aebersold R, Bähler J | title = Quantitative analysis of fission yeast transcriptomes and proteomes in proliferating and quiescent cells | journal = Cell | volume = 151 | issue = 3 | pages = 671–83 | date = October 2012 | pmid = 23101633 | pmc = 3482660 | doi = 10.1016/j.cell.2012.09.019 }} In one example, this technique was used in ''[[w:Xenopus tropicalis|Xenopus tropicalis]]'' embryos to determine transcription kinetics.{{cite journal | vauthors = Owens ND, Blitz IL, Lane MA, Patrushev I, Overton JD, Gilchrist MJ, Cho KW, Khokha MK | title = Measuring Absolute RNA Copy Numbers at High Temporal Resolution Reveals Transcriptome Kinetics in Development | journal = Cell Reports | volume = 14 | issue = 3 | pages = 632–647 | date = January 2016 | pmid = 26774488 | pmc = 4731879 | doi = 10.1016/j.celrep.2015.12.050 }} [125] => * ''Detection of genome-wide effects:'' Changes in global regulators including [[Chromatin remodeling|chromatin remodelers]], [[transcription factors]] (e.g., [[Myc|MYC]]), [[acetyltransferase]] complexes, and nucleosome positioning are not congruent with normalization assumptions and spike-in controls can offer precise interpretation.{{cite journal | vauthors = Chen K, Hu Z, Xia Z, Zhao D, Li W, Tyler JK | title = The Overlooked Fact: Fundamental Need for Spike-In Control for Virtually All Genome-Wide Analyses | journal = Molecular and Cellular Biology | volume = 36 | issue = 5 | pages = 662–7 | date = December 2015 | pmid = 26711261 | pmc = 4760223 | doi = 10.1128/MCB.00970-14 }}{{cite journal | vauthors = Lovén J, Orlando DA, Sigova AA, Lin CY, Rahl PB, Burge CB, Levens DL, Lee TI, Young RA | title = Revisiting global gene expression analysis | journal = Cell | volume = 151 | issue = 3 | pages = 476–82 | date = October 2012 | pmid = 23101621 | pmc = 3505597 | doi = 10.1016/j.cell.2012.10.012 }} [126] => [127] => === Differential expression === [128] => [129] => The simplest but often most powerful use of RNA-Seq is finding differences in gene expression between two or more conditions (''e.g.'', treated vs not treated); this process is called differential expression. The outputs are frequently referred to as differentially expressed genes (DEGs) and these genes can either be up- or down-regulated (''i.e.'', higher or lower in the condition of interest). There are many [[List of RNA-Seq bioinformatics tools#Normalization, quantitative analysis and differential expression|tools that perform differential expression]]. Most are run in [[R (programming language)|R]], [[Python (programming language)|Python]], or the [[Unix]] command line. Commonly used tools include DESeq, edgeR, and voom+limma,{{cite journal | vauthors = Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK | title = limma powers differential expression analyses for RNA-sequencing and microarray studies | journal = Nucleic Acids Research | volume = 43 | issue = 7 | pages = e47 | date = April 2015 | pmid = 25605792 | pmc = 4402510 | doi = 10.1093/nar/gkv007 }} all of which are available through R/[[Bioconductor]].{{cite web | url = http://www.bioconductor.org | title = Bioconductor - Open source software for bioinformatics}}{{cite journal | vauthors = Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, Bravo HC, Davis S, Gatto L, Girke T, Gottardo R, Hahne F, Hansen KD, Irizarry RA, Lawrence M, Love MI, MacDonald J, Obenchain V, Oleś AK, Pagès H, Reyes A, Shannon P, Smyth GK, Tenenbaum D, Waldron L, Morgan M | title = Orchestrating high-throughput genomic analysis with Bioconductor | journal = Nature Methods | volume = 12 | issue = 2 | pages = 115–21 | date = February 2015 | pmid = 25633503 | pmc = 4509590 | doi = 10.1038/nmeth.3252 }} These are the common considerations when performing differential expression: [130] => [131] => * ''Inputs:'' Differential expression inputs include (1) an RNA-Seq expression matrix (M genes x N samples) and (2) a [[design matrix]] containing experimental conditions for N samples. The simplest design matrix contains one column, corresponding to labels for the condition being tested. Other covariates (also referred to as factors, features, labels, or parameters) can include [[batch effect]]s, known artifacts, and any metadata that might confound or mediate gene expression. In addition to known covariates, unknown covariates can also be estimated through [[unsupervised machine learning]] approaches including [[Principal component analysis|principal component]], surrogate variable,{{cite journal | vauthors = Leek JT, Storey JD | title = Capturing heterogeneity in gene expression studies by surrogate variable analysis | journal = PLOS Genetics | volume = 3 | issue = 9 | pages = 1724–35 | date = September 2007 | pmid = 17907809 | pmc = 1994707 | doi = 10.1371/journal.pgen.0030161 | doi-access = free }} and PEER analyses. Hidden variable analyses are often employed for human tissue RNA-Seq data, which typically have additional artifacts not captured in the metadata (''e.g.'', ischemic time, sourcing from multiple institutions, underlying clinical traits, collecting data across many years with many personnel). [132] => * ''Methods:'' Most tools use [[w:Regression analysis|regression]] or [[w:non-parametric statistics|non-parametric statistics]] to identify differentially expressed genes, and are either based on read counts mapped to a reference genome (DESeq2, limma, edgeR) or based on read counts derived from alignment-free quantification (sleuth,{{cite journal | vauthors = Pimentel H, Bray NL, Puente S, Melsted P, Pachter L | title = Differential analysis of RNA-seq incorporating quantification uncertainty | journal = Nature Methods | volume = 14 | issue = 7 | pages = 687–690 | date = July 2017 | pmid = 28581496 | doi = 10.1038/nmeth.4324 | s2cid = 15063247 | url = https://resolver.caltech.edu/CaltechAUTHORS:20170612-084553487 }} Cuffdiff,{{cite journal | vauthors = Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L | title = Differential analysis of gene regulation at transcript resolution with RNA-seq | journal = Nature Biotechnology | volume = 31 | issue = 1 | pages = 46–53 | date = January 2013 | pmid = 23222703 | doi = 10.1038/nbt.2450 | pmc = 3869392 }} Ballgown{{cite journal | vauthors = Frazee AC, Pertea G, Jaffe AE, Langmead B, Salzberg SL, Leek JT | title = Ballgown bridges the gap between transcriptome assembly and expression analysis | journal = Nature Biotechnology | volume = 33 | issue = 3 | pages = 243–6 | date = March 2015 | pmid = 25748911 | doi = 10.1038/nbt.3172 | pmc = 4792117 }}).{{cite journal | vauthors = Sahraeian SM, Mohiyuddin M, Sebra R, Tilgner H, Afshar PT, Au KF, Bani Asadi N, Gerstein MB, Wong WH, Snyder MP, Schadt E, Lam HY | title = Gaining comprehensive biological insight into the transcriptome by performing a broad-spectrum RNA-seq analysis | journal = Nature Communications | volume = 8 | issue = 1 | pages = 59 | date = July 2017 | pmid = 28680106 | doi = 10.1038/s41467-017-00050-4 | pmc = 5498581 | bibcode = 2017NatCo...8...59S }} Following regression, most tools employ either [[w:Family-wise error rate|familywise error rate (FWER)]] or [[w:False discovery rate|false discovery rate (FDR)]] p-value adjustments to account for [[w:Multiple comparisons problem|multiple hypotheses]] (in human studies, ~20,000 protein-coding genes or ~50,000 biotypes). [133] => * ''Outputs:'' A typical output consists of rows corresponding to the number of genes and at least three columns, each gene's log [[fold change]] ([[log-transform]] of the ratio in expression between conditions, a measure of [[effect size]]), [[p-value]], and p-value adjusted for [[Multiple comparisons problem|multiple comparisons]]. Genes are defined as biologically meaningful if they pass cut-offs for effect size (log fold change) and [[statistical significance]]. These cut-offs should ideally be specified ''a priori'', but the nature of RNA-Seq experiments is often exploratory so it is difficult to predict effect sizes and pertinent cut-offs ahead of time. [134] => * ''Pitfalls:'' The raison d'etre for these complex methods is to avoid the myriad of pitfalls that can lead to [[Type I and type II errors|statistical errors]] and misleading interpretations. Pitfalls include increased false positive rates (due to multiple comparisons), sample preparation artifacts, sample heterogeneity (like mixed genetic backgrounds), highly correlated samples, unaccounted for [[Multilevel model|multi-level experimental designs]], and poor [[Design of experiments|experimental design]]. One notable pitfall is viewing results in Microsoft Excel without using the import feature to ensure that the gene names remain text.{{cite journal | vauthors = Ziemann M, Eren Y, El-Osta A | title = Gene name errors are widespread in the scientific literature | journal = Genome Biology | volume = 17 | issue = 1 | pages = 177 | date = August 2016 | pmid = 27552985 | pmc = 4994289 | doi = 10.1186/s13059-016-1044-7 | doi-access = free }} Although convenient, Excel automatically converts some gene names (''[[SEPT1]], [[DEC1]], [[MARCH2]]'') into dates or floating point numbers. [135] => * ''Choice of tools and benchmarking:'' There are numerous efforts that compare the results of these tools, with DESeq2 tending to moderately outperform other methods.{{cite journal | vauthors = Soneson C, Delorenzi M | title = A comparison of methods for differential expression analysis of RNA-seq data | journal = BMC Bioinformatics | volume = 14 | pages = 91 | date = March 2013 | pmid = 23497356 | pmc = 3608160 | doi = 10.1186/1471-2105-14-91 | doi-access = free }}{{cite journal | vauthors = Fonseca NA, Marioni J, Brazma A | title = RNA-Seq gene profiling--a systematic empirical comparison | journal = PLOS ONE | volume = 9 | issue = 9 | pages = e107026 | date = 30 September 2014 | pmid = 25268973 | pmc = 4182317 | doi = 10.1371/journal.pone.0107026 | bibcode = 2014PLoSO...9j7026F | doi-access = free }}{{cite journal | vauthors = Seyednasrollah F, Laiho A, Elo LL | title = Comparison of software packages for detecting differential expression in RNA-seq studies | journal = Briefings in Bioinformatics | volume = 16 | issue = 1 | pages = 59–70 | date = January 2015 | pmid = 24300110 | pmc = 4293378 | doi = 10.1093/bib/bbt086 }}{{cite journal | vauthors = Rapaport F, Khanin R, Liang Y, Pirun M, Krek A, Zumbo P, Mason CE, Socci ND, Betel D | title = Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data | journal = Genome Biology | volume = 14 | issue = 9 | pages = R95 | date = 2013 | pmid = 24020486 | pmc = 4054597 | doi = 10.1186/gb-2013-14-9-r95 | doi-access = free }}{{cite journal | vauthors = Costa-Silva J, Domingues D, Lopes FM | title = RNA-Seq differential expression analysis: An extended review and a software tool | journal = PLOS ONE | volume = 12 | issue = 12 | pages = e0190152 | date = 21 December 2017 | pmid = 29267363 | pmc = 5739479 | doi = 10.1371/journal.pone.0190152 | bibcode = 2017PLoSO..1290152C | doi-access = free }}{{cite journal | vauthors = Corchete LA, Rojas EA, Alonso-López D, De Las Rivas J, Gutiérrez NC, Burguillo FJ | title = Systematic comparison and assessment of RNA-seq procedures for gene expression quantitative analysis | journal = Scientific Reports | volume = 12 | issue = 10 | pages = 19737 | date = 12 November 2020 | pmid = 33184454 | pmc = 7665074 | doi = 10.1038/s41598-020-76881-x | bibcode = 2020NatSR..1019737C | doi-access = free }} As with other methods, benchmarking consists of comparing tool outputs to each other and known [[Gold standard (test)|gold standards]]. [136] => [137] => Downstream analyses for a list of differentially expressed genes come in two flavors, validating observations and making biological inferences. Owing to the pitfalls of differential expression and RNA-Seq, important observations are replicated with (1) an orthogonal method in the same samples (like [[w:Real-time polymerase chain reaction|real-time PCR]]) or (2) another, sometimes [[w:Pre-registration (science)|pre-registered]], experiment in a new cohort. The latter helps ensure generalizability and can typically be followed up with a meta-analysis of all the pooled cohorts. The most common method for obtaining higher-level biological understanding of the results is [[w:gene set enrichment analysis|gene set enrichment analysis]], although sometimes candidate gene approaches are employed. Gene set enrichment determines if the overlap between two gene sets is statistically significant, in this case the overlap between differentially expressed genes and gene sets from known pathways/databases (''e.g.'', [[w:Gene Ontology|Gene Ontology]], [[w:KEGG|KEGG]], [[w:Human Phenotype Ontology|Human Phenotype Ontology]]) or from complementary analyses in the same data (like co-expression networks). Common tools for gene set enrichment include web interfaces (''e.g.'', ENRICHR, g:profiler, WEBGESTALT){{cite journal | vauthors = Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B | title = WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs | journal = Nucleic Acids Research | volume = 47 | issue = W1 | pages = W199–W205 | date = July 2019 | pmid = 31114916 | pmc = 6602449 | doi = 10.1093/nar/gkz401 }} and software packages. When evaluating enrichment results, one heuristic is to first look for enrichment of known biology as a sanity check and then expand the scope to look for novel biology. [138] => [139] => [[file:Alt splicing bestiary2.jpg|thumb|Examples of alternative RNA splicing modes. Exons are represented as blue and yellow blocks, spliced introns as horizontal black lines connecting two exons, and exon-exon junctions as thin grey connecting lines between two exons. [140] => ]] [141] => [142] => ===Alternative splicing=== [143] => [144] => [[RNA splicing]] is integral to eukaryotes and contributes significantly to protein regulation and diversity, occurring in >90% of human genes.{{cite journal | vauthors = Keren H, Lev-Maor G, Ast G | title = Alternative splicing and evolution: diversification, exon definition and function | journal = Nature Reviews. Genetics | volume = 11 | issue = 5 | pages = 345–55 | date = May 2010 | pmid = 20376054 | doi = 10.1038/nrg2776 | s2cid = 5184582 }} There are multiple [[Alternative splicing#Modes|alternative splicing modes]]: exon skipping (most common splicing mode in humans and higher eukaryotes), mutually exclusive exons, alternative donor or acceptor sites, intron retention (most common splicing mode in plants, fungi, and protozoa), alternative transcription start site (promoter), and alternative polyadenylation. One goal of RNA-Seq is to identify alternative splicing events and test if they differ between conditions. Long-read sequencing captures the full transcript and thus minimizes many of issues in estimating isoform abundance, like ambiguous read mapping. For short-read RNA-Seq, there are multiple methods to detect alternative splicing that can be classified into three main groups:{{cite journal | vauthors = Liu R, Loraine AE, Dickerson JA | title = Comparisons of computational methods for differential alternative splicing detection using RNA-seq in plant systems | journal = BMC Bioinformatics | volume = 15 | issue = 1 | pages = 364 | date = December 2014 | pmid = 25511303 | pmc = 4271460 | doi = 10.1186/s12859-014-0364-4 | doi-access = free }}{{cite journal | vauthors = Li YI, Knowles DA, Humphrey J, Barbeira AN, Dickinson SP, Im HK, Pritchard JK | title = Annotation-free quantification of RNA splicing using LeafCutter | journal = Nature Genetics | volume = 50 | issue = 1 | pages = 151–158 | date = January 2018 | pmid = 29229983 | pmc = 5742080 | doi = 10.1038/s41588-017-0004-9 }} [145] => * ''Count-based (also event-based, differential splicing):'' estimate exon retention. Examples are DEXSeq,{{cite journal | vauthors = Anders S, Reyes A, Huber W | title = Detecting differential usage of exons from RNA-seq data | journal = Genome Research | volume = 22 | issue = 10 | pages = 2008–17 | date = October 2012 | pmid = 22722343 | pmc = 3460195 | doi = 10.1101/gr.133744.111 }} MATS,{{cite journal | vauthors = Shen S, Park JW, Huang J, Dittmar KA, Lu ZX, Zhou Q, Carstens RP, Xing Y | title = MATS: a Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data | journal = Nucleic Acids Research | volume = 40 | issue = 8 | pages = e61 | date = April 2012 | pmid = 22266656 | pmc = 3333886 | doi = 10.1093/nar/gkr1291 }} and SeqGSEA.{{cite journal | vauthors = Wang X, Cairns MJ | title = SeqGSEA: a Bioconductor package for gene set enrichment analysis of RNA-Seq data integrating differential expression and splicing | journal = Bioinformatics | volume = 30 | issue = 12 | pages = 1777–9 | date = June 2014 | pmid = 24535097 | doi = 10.1093/bioinformatics/btu090 | doi-access = free }} [146] => * ''Isoform-based (also multi-read modules, differential isoform expression)'': estimate isoform abundance first, and then relative abundance between conditions. Examples are Cufflinks 2{{cite journal | vauthors = Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L | title = Differential analysis of gene regulation at transcript resolution with RNA-seq | journal = Nature Biotechnology | volume = 31 | issue = 1 | pages = 46–53 | date = January 2013 | pmid = 23222703 | pmc = 3869392 | doi = 10.1038/nbt.2450 }} and DiffSplice.{{cite journal | vauthors = Hu Y, Huang Y, Du Y, Orellana CF, Singh D, Johnson AR, Monroy A, Kuan PF, Hammond SM, Makowski L, Randell SH, Chiang DY, Hayes DN, Jones C, Liu Y, Prins JF, Liu J | title = DiffSplice: the genome-wide detection of differential splicing events with RNA-seq | journal = Nucleic Acids Research | volume = 41 | issue = 2 | pages = e39 | date = January 2013 | pmid = 23155066 | pmc = 3553996 | doi = 10.1093/nar/gks1026 }} [147] => * ''Intron excision based:'' calculate alternative splicing using split reads. Examples are MAJIQ{{cite journal | vauthors = Vaquero-Garcia J, Barrera A, Gazzara MR, González-Vallinas J, Lahens NF, Hogenesch JB, Lynch KW, Barash Y | title = A new view of transcriptome complexity and regulation through the lens of local splicing variations | journal = eLife | volume = 5 | pages = e11752 | date = February 2016 | pmid = 26829591 | pmc = 4801060 | doi = 10.7554/eLife.11752 | doi-access = free }} and Leafcutter. [148] => [149] => Differential gene expression tools can also be used for differential isoform expression if isoforms are quantified ahead of time with other tools like RSEM.{{cite journal | vauthors = Merino GA, Conesa A, Fernández EA | title = A benchmarking of workflows for detecting differential splicing and differential expression at isoform level in human RNA-seq studies | journal = Briefings in Bioinformatics | volume = 20 | issue = 2 | pages = 471–481 | date = March 2019 | pmid = 29040385 | doi = 10.1093/bib/bbx122 | s2cid = 22706028 }} [150] => [151] => ===Coexpression networks=== [152] => Coexpression networks are data-derived representations of genes behaving in a similar way across tissues and experimental conditions.{{cite journal | vauthors = Marcotte EM, Pellegrini M, Thompson MJ, Yeates TO, Eisenberg D | title = A combined algorithm for genome-wide prediction of protein function | journal = Nature | volume = 402 | issue = 6757 | pages = 83–6 | date = November 1999 | pmid = 10573421 | doi = 10.1038/47048 | bibcode = 1999Natur.402...83M | s2cid = 144447 }} Their main purpose lies in hypothesis generation and guilt-by-association approaches for inferring functions of previously unknown genes. RNA-Seq data has been used to infer genes involved in specific pathways based on [[Pearson correlation]], both in plants{{cite journal | vauthors = Giorgi FM, Del Fabbro C, Licausi F | title = Comparative study of RNA-seq- and microarray-derived coexpression networks in Arabidopsis thaliana | journal = Bioinformatics | volume = 29 | issue = 6 | pages = 717–24 | date = March 2013 | pmid = 23376351 | doi = 10.1093/bioinformatics/btt053 | doi-access = free | hdl = 11390/990155 | hdl-access = free }} and mammals.{{cite journal | vauthors = Iancu OD, Kawane S, Bottomly D, Searles R, Hitzemann R, McWeeney S | title = Utilizing RNA-Seq data for de novo coexpression network inference | journal = Bioinformatics | volume = 28 | issue = 12 | pages = 1592–7 | date = June 2012 | pmid = 22556371 | pmc = 3493127 | doi = 10.1093/bioinformatics/bts245 }} The main advantage of RNA-Seq data in this kind of analysis over the microarray platforms is the capability to cover the entire transcriptome, therefore allowing the possibility to unravel more complete representations of the gene regulatory networks. Differential regulation of the splice isoforms of the same gene can be detected and used to predict their biological functions.{{cite journal | vauthors = Eksi R, Li HD, Menon R, Wen Y, Omenn GS, Kretzler M, Guan Y | title = Systematically differentiating functions for alternatively spliced isoforms through integrating RNA-seq data | journal = PLOS Computational Biology | volume = 9 | issue = 11 | pages = e1003314 | date = November 2013 | pmid = 24244129 | pmc = 3820534 | doi = 10.1371/journal.pcbi.1003314 | bibcode = 2013PLSCB...9E3314E | doi-access = free }}{{cite journal | vauthors = Li HD, Menon R, Omenn GS, Guan Y | title = The emerging era of genomic data integration for analyzing splice isoform function | journal = Trends in Genetics | volume = 30 | issue = 8 | pages = 340–7 | date = August 2014 | pmid = 24951248 | pmc = 4112133 | doi = 10.1016/j.tig.2014.05.005 }} [153] => [[Weighted correlation network analysis|Weighted gene co-expression network analysis]] has been successfully used to identify co-expression modules and intramodular hub genes based on RNA seq data. Co-expression modules may correspond to cell types or pathways. Highly connected intramodular hubs can be interpreted as representatives of their respective module. An eigengene is a weighted sum of expression of all genes in a module. Eigengenes are useful biomarkers (features) for diagnosis and prognosis.{{cite journal | vauthors = Foroushani A, Agrahari R, Docking R, Chang L, Duns G, Hudoba M, Karsan A, Zare H | title = Large-scale gene network analysis reveals the significance of extracellular matrix pathway and homeobox genes in acute myeloid leukemia: an introduction to the Pigengene package and its applications | journal = BMC Medical Genomics | volume = 10 | issue = 1 | pages = 16 | date = March 2017 | pmid = 28298217 | pmc = 5353782 | doi = 10.1186/s12920-017-0253-6 | doi-access = free }} Variance-Stabilizing Transformation approaches for estimating correlation coefficients based on RNA seq data have been proposed. [154] => [155] => ===Variant discovery=== [156] => [157] => RNA-Seq captures DNA variation, including [[w:single nucleotide variants|single nucleotide variants]], [[w:Indel|small insertions/deletions]]. and [[w:structural variation|structural variation]]. [[w:SNV calling from NGS data|Variant calling]] in RNA-Seq is similar to DNA variant calling and often employs the same tools (including SAMtools mpileup{{cite journal | vauthors = Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R | title = The Sequence Alignment/Map format and SAMtools | journal = Bioinformatics | volume = 25 | issue = 16 | pages = 2078–9 | date = August 2009 | pmid = 19505943 | doi = 10.1093/bioinformatics/btp352 | pmc = 2723002 }} and GATK HaplotypeCaller{{cite journal | vauthors = DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ | title = A framework for variation discovery and genotyping using next-generation DNA sequencing data | journal = Nature Genetics | volume = 43 | issue = 5 | pages = 491–8 | date = May 2011 | pmid = 21478889 | doi = 10.1038/ng.806 | pmc = 3083463 }}) with adjustments to account for splicing. One unique dimension for RNA variants is [[w:Monoallelic gene expression|allele-specific expression (ASE)]]: the variants from only one haplotype might be preferentially expressed due to regulatory effects including [[w:Genomic imprinting|imprinting]] and [[w:expression quantitative trait loci|expression quantitative trait loci]], and noncoding [[w:Rare functional variant|rare variants]].{{cite journal | vauthors = Battle A, Brown CD, Engelhardt BE, Montgomery SB | title = Genetic effects on gene expression across human tissues | journal = Nature | volume = 550 | issue = 7675 | pages = 204–213 | date = October 2017 | pmid = 29022597 | doi = 10.1038/nature24277 | pmc = 5776756 | bibcode = 2017Natur.550..204A | hdl = 10230/34202 | hdl-access = free }}{{cite journal | vauthors = Richter F, Hoffman GE, Manheimer KB, Patel N, Sharp AJ, McKean D, Morton SU, DePalma S, Gorham J, Kitaygorodksy A, Porter GA, Giardini A, Shen Y, Chung WK, Seidman JG, Seidman CE, Schadt EE, Gelb BD | title = ORE identifies extreme expression effects enriched for rare variants | journal = Bioinformatics | volume = 35 | issue = 20 | pages = 3906–3912 | date = October 2019 | pmid = 30903145 | doi = 10.1093/bioinformatics/btz202 | pmc = 6792115 }} Limitations of RNA variant identification include that it only reflects expressed regions (in humans, <5% of the genome), could be subject to biases introduced by data processing (e.g., de novo transcriptome assemblies underestimate heterozygosity{{cite journal | vauthors = Freedman AH, Clamp M, Sackton TB | title = Error, noise and bias in de novo transcriptome assemblies | journal = Molecular Ecology Resources | volume = 21 | issue = 1 | pages = 18–29 | date = January 2021 | pmid = 32180366 | doi = 10.1111/1755-0998.13156 | s2cid = 212739959 }}), and has lower quality when compared to direct DNA sequencing. [158] => [159] => ====RNA editing (post-transcriptional alterations)==== [160] => {{See also|RNA editing}} [161] => Having the matching genomic and transcriptomic sequences of an individual can help detect post-transcriptional edits ([[RNA editing]]). A post-transcriptional modification event is identified if the gene's transcript has an allele/variant not observed in the genomic data. [162] => [163] => [[file:RNA-Seq-fusion-gene.png|thumb|A gene fusion event and the behaviour of paired-end reads falling on both sides of the gene union. Gene fusions can occur in ''Trans'', between genes on separate chromosomes, or in ''Cis'', between two genes on the same chromosome.]] [164] => [165] => ===Fusion gene detection=== [166] => [167] => {{See also|Fusion gene}} [168] => [169] => Caused by different structural modifications in the genome, fusion genes have gained attention because of their relationship with cancer.{{cite journal | vauthors = Teixeira MR | title = Recurrent fusion oncogenes in carcinomas | journal = Critical Reviews in Oncogenesis | volume = 12 | issue = 3–4 | pages = 257–71 | date = December 2006 | pmid = 17425505 | doi = 10.1615/critrevoncog.v12.i3-4.40 | s2cid = 40770452 }} The ability of RNA-Seq to analyze a sample's whole transcriptome in an unbiased fashion makes it an attractive tool to find these kinds of common events in cancer.{{cite journal | vauthors = Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM | title = Transcriptome sequencing to detect gene fusions in cancer | journal = Nature | volume = 458 | issue = 7234 | pages = 97–101 | date = March 2009 | pmid = 19136943 | pmc = 2725402 | doi = 10.1038/nature07638 | bibcode = 2009Natur.458...97M }} [170] => [171] => The idea follows from the process of aligning the short transcriptomic reads to a reference genome. Most of the short reads will fall within one complete exon, and a smaller but still large set would be expected to map to known exon-exon junctions. The remaining unmapped short reads would then be further analyzed to determine whether they match an exon-exon junction where the exons come from different genes. This would be evidence of a possible fusion event, however, because of the length of the reads, this could prove to be very noisy. An alternative approach is to use paired-end reads, when a potentially large number of paired reads would map each end to a different exon, giving better coverage of these events (see figure). Nonetheless, the end result consists of multiple and potentially novel combinations of genes providing an ideal starting point for further validation. [172] => [173] => === Copy number alteration === [174] => [175] => [[Copy number alteration]] (CNA) analyses are commonly used in cancer studies. Gain and loss of the genes have signalling pathway implications and are a key biomarker of molecular dysfunction in oncology. Calling the CNA information from RNA-Seq data is not straightforward because of the differences in gene expression, which lead to the read depth variance of different magnitudes across genes. Due to these difficulties, most of these analyses are usually done using whole-genome sequencing / whole-exome sequencing (WGS/WES). But advanced bioinformatics tools can call CNA from  RNA-Seq.{{cite journal | vauthors = Thind AS, Monga I, Thakur PK, Kumari P, Dindhoria K, Krzak M, Ranson M, Ashford B | title = Demystifying emerging bulk RNA-Seq applications: the application and utility of bioinformatic methodology | journal = Briefings in Bioinformatics | volume = 22 | issue = 6 | date = November 2021 | pmid = 34329375 | doi = 10.1093/bib/bbab259 }} [176] => [177] => === Other emerging analysis and applications === [178] => [179] => The applications of RNA-Seq are growing day by day. Other new application of RNA-Seq includes detection of microbial contaminants,{{cite journal | vauthors = Sangiovanni M, Granata I, Thind AS, Guarracino MR | title = From trash to treasure: detecting unexpected contamination in unmapped NGS data | journal = BMC Bioinformatics | volume = 20 | issue = Suppl 4 | pages = 168 | date = April 2019 | pmid = 30999839 | pmc = 6472186 | doi = 10.1186/s12859-019-2684-x | doi-access = free }} determining cell type abundance (cell type deconvolution), measuring the expression of TEs and Neoantigen prediction etc. [180] => [181] => ==History== [182] => [183] => [[file:RNAseq over time (Pubmed).png|thumb|Pubmed manuscript matches highlight the growing popularity of RNA-Seq. Matches are for RNA-Seq (blue, search terms: "RNA Seq" OR "RNA-Seq" OR "RNA sequencing" OR "RNASeq"){{Cite web|title=PubMed search: "RNA Seq" OR "RNA-Seq" OR "RNA sequencing" OR "RNASeq"|url=https://pubmed.ncbi.nlm.nih.gov/?term=%22RNA+Seq%22+OR+%22RNA-Seq%22+OR+%22RNA+sequencing%22+OR+%22RNASeq%22|access-date=20 June 2021|website=PubMed|language=en}} and RNA=Seq in medicine (gold, search terms: ("RNA Seq" OR "RNA-Seq" OR "RNA sequencing" OR "RNASeq") AND "Medicine").{{Cite web|title=PubMed search: ("RNA Seq" OR "RNA-Seq" OR "RNA sequencing" OR "RNASeq") AND "Medicine"|url=https://pubmed.ncbi.nlm.nih.gov/?term=(%22RNA+Seq%22+OR+%22RNA-Seq%22+OR+%22RNA+sequencing%22+OR+%22RNASeq%22)+AND+%22Medicine%22|access-date=20 June 2021|website=PubMed|language=en}} The number of manuscripts on PubMed featuring RNA-Seq is still increasing.]] [184] => [185] => RNA-Seq was first developed in mid 2000s with the advent of next-generation sequencing technology.{{cite journal | vauthors = Weber AP | title = Discovering New Biology through Sequencing of RNA | journal = Plant Physiology | volume = 169 | issue = 3 | pages = 1524–31 | date = November 2015 | pmid = 26353759 | pmc = 4634082 | doi = 10.1104/pp.15.01081 }} The first manuscripts that used RNA-Seq even without using the term includes those of [[prostate cancer]] [[cell lines]]{{cite journal | vauthors = Bainbridge MN, Warren RL, Hirst M, Romanuik T, Zeng T, Go A, Delaney A, Griffith M, Hickenbotham M, Magrini V, Mardis ER, Sadar MD, Siddiqui AS, Marra MA, Jones SJ | title = Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach | journal = BMC Genomics | volume = 7 | pages = 246 | date = September 2006 | pmid = 17010196 | pmc = 1592491 | doi = 10.1186/1471-2164-7-246 | doi-access = free }} (dated 2006), ''[[Medicago truncatula]]''{{cite journal | vauthors = Cheung F, Haas BJ, Goldberg SM, May GD, Xiao Y, Town CD | title = Sequencing Medicago truncatula expressed sequenced tags using 454 Life Sciences technology | journal = BMC Genomics | volume = 7 | pages = 272 | date = October 2006 | pmid = 17062153 | pmc = 1635983 | doi = 10.1186/1471-2164-7-272 | doi-access = free }} (2006), maize{{cite journal | vauthors = Emrich SJ, Barbazuk WB, Li L, Schnable PS | title = Gene discovery and annotation using LCM-454 transcriptome sequencing | journal = Genome Research | volume = 17 | issue = 1 | pages = 69–73 | date = January 2007 | pmid = 17095711 | pmc = 1716268 | doi = 10.1101/gr.5145806 }} (2007), and ''[[Arabidopsis thaliana]]''{{cite journal | vauthors = Weber AP, Weber KL, Carr K, Wilkerson C, Ohlrogge JB | title = Sampling the Arabidopsis transcriptome with massively parallel pyrosequencing | journal = Plant Physiology | volume = 144 | issue = 1 | pages = 32–42 | date = May 2007 | pmid = 17351049 | pmc = 1913805 | doi = 10.1104/pp.107.096677 }} (2007), while the term "RNA-Seq" itself was first mentioned in 2008.{{cite journal | vauthors = Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D, Gerstein M, Snyder M | title = The transcriptional landscape of the yeast genome defined by RNA sequencing | journal = Science | volume = 320 | issue = 5881 | pages = 1344–9 | date = June 2008 | pmid = 18451266 | pmc = 2951732 | doi = 10.1126/science.1158441 | bibcode = 2008Sci...320.1344N }} The number of manuscripts referring to RNA-Seq in the title or abstract (Figure, blue line) is continuously increasing with 6754 manuscripts published in 2018. The intersection of RNA-Seq and medicine (Figure, gold line) has similar celerity.{{Cite journal| vauthors = Richter F |date=2021|title=A broad introduction to RNA-Seq|url=https://en.wikiversity.org/wiki/WikiJournal_of_Science/A_broad_introduction_to_RNA-Seq|journal=WikiJournal of Science|volume=4|issue=1|pages=4|doi=10.15347/WJS/2021.004|doi-access=free}} [186] => [187] => ===Applications to medicine=== [188] => RNA-Seq has the potential to identify new disease biology, profile biomarkers for clinical indications, infer druggable pathways, and make genetic diagnoses. These results could be further personalized for subgroups or even individual patients, potentially highlighting more effective prevention, diagnostics, and therapy. The feasibility of this approach is in part dictated by costs in money and time; a related limitation is the required team of specialists (bioinformaticians, physicians/clinicians, basic researchers, technicians) to fully interpret the huge amount of data generated by this analysis.{{cite journal | vauthors = Sandberg R | title = Entering the era of single-cell transcriptomics in biology and medicine | journal = Nature Methods | volume = 11 | issue = 1 | pages = 22–4 | date = January 2014 | pmid = 24524133 | doi = 10.1038/nmeth.2764 | s2cid = 27632439 | url = https://zenodo.org/record/890299 }} [189] => [190] => ===Large-scale sequencing efforts=== [191] => A lot of emphasis has been given to RNA-Seq data after the [[ENCODE|Encyclopedia of DNA Elements (ENCODE)]] and [[The Cancer Genome Atlas]] (TCGA) projects have used this approach to characterize dozens of cell lines{{cite web |url= http://genome.ucsc.edu/ENCODE/dataMatrix/encodeDataMatrixHuman.html |title=ENCODE Data Matrix |access-date=28 July 2013}} and thousands of primary tumor samples,{{cite web |url=https://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp |title=The Cancer Genome Atlas – Data Portal |access-date=28 July 2013}} respectively. ENCODE aimed to identify genome-wide regulatory regions in different cohort of cell lines and transcriptomic data are paramount to understand the downstream effect of those epigenetic and genetic regulatory layers. TCGA, instead, aimed to collect and analyze thousands of patient's samples from 30 different tumor types to understand the underlying mechanisms of malignant transformation and progression. In this context RNA-Seq data provide a unique snapshot of the transcriptomic status of the disease and look at an unbiased population of transcripts that allows the identification of novel transcripts, fusion transcripts and non-coding RNAs that could be undetected with different technologies. [192] => [193] => == See also == [194] => * [[Transcriptomics]] [195] => * [[DNA microarray]] [196] => * [[List of RNA-Seq bioinformatics tools]] [197] => [198] => == References == [199] => {{Academic peer reviewed|Q=Q100146647}}{{Reflist|2}} [200] => [201] => == Further reading == [202] => {{refbegin}} [203] => * {{cite book |doi=10.1016/B978-0-12-809633-8.20163-5 |chapter=Comparative Transcriptomics Analysis |title=Encyclopedia of Bioinformatics and Computational Biology |pages=814–818 |year=2019 | vauthors = Taguchi Y |isbn=978-0-12-811432-2 |s2cid=65302519 }} [204] => {{refend}} [205] => [206] => == External links == [207] => {{Scholia|topic}} [208] => * {{cite web | vauthors = Cresko B, Voelker R, Small C | date = 2001 | veditors = Bassham S, Catchen J | publisher = University of Oregon | title = RNA-seqlopedia | url = http://rnaseq.uoregon.edu/index.html }}: a high-level guide to designing and implementing an RNA-Seq experiment. [209] => [210] => {{DEFAULTSORT:Rna-Seq}} [211] => [[Category:Molecular biology]] [212] => [[Category:RNA]] [213] => [[Category:Gene expression]] [214] => [[Category:RNA sequencing]] [] => )
good wiki

RNA-Seq

RNA-Seq is a high-throughput sequencing technique used to analyze the transcriptome of an organism. It involves the generation of cDNA libraries from RNA molecules, which are then sequenced using next-generation sequencing technologies.

More about us

About

It involves the generation of cDNA libraries from RNA molecules, which are then sequenced using next-generation sequencing technologies. The resulting sequences can be aligned to a reference genome or transcriptome to quantify gene expression levels, identify novel transcripts, detect alternative splicing events, and study other aspects of RNA biology. RNA-Seq has revolutionized the field of transcriptomics and has become widely used in biological research, including gene expression profiling, biomarker discovery, and functional genomics studies. This Wikipedia page provides a detailed overview of RNA-Seq, its applications, data analysis methods, and limitations. It also discusses the advantages of RNA-Seq over traditional methods and provides examples of its implementation in various scientific studies.

Expert Team

Vivamus eget neque lacus. Pellentesque egauris ex.

Award winning agency

Lorem ipsum, dolor sit amet consectetur elitorceat .

10 Year Exp.

Pellen tesque eget, mauris lorem iupsum neque lacus.